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Abstract
Gametogenesis and early embryogenesis are important stages in which genomewide epigenetic transitions required for early mammalian development are orchestrated.
This is exemplified by the occurrence of genomic imprinting, where epigenetic
mechanisms lead to the monoallelic expression of a subset of genes. Parental-specific
DNA methylation in the gametes results in the distinct nonequivalence of the parental
genomes in the early embryo. Changes from normal gamete and embryo development by
impaired fertility or assisted reproductive technologies (ARTs) may disrupt the processes
of imprint acquisition and imprint maintenance. My hypothesis is that aberrant imprinted
methylation

arises

from

impaired

maternal

fertility

or

ovarian

stimulation

(superovulation), and that maternal effect factors involved in imprint regulation are
disrupted by ARTs. To evaluate this, I developed a single cell methylation assay to
determine DNA methylation patterns in individual oocytes and preimplantation embryos.
I used this technique to examine the effects of compromised maternal fertility on imprint
acquisition at three imprinted genes in growing oocytes, revealing that Peg1 DNA
methylation acquisition was arrested in CX37-null oocytes, but not Snrpn or Peg3. I also
used this technique to assess the effects of superovulation on imprint acquisition at four
imprinted genes in MII oocytes, showing that imprint acquisition was unaffected at
Snrpn, Kcnq1ot1, Peg3 and H19. Finally, I determined the effects of superovulation on
the maternal effect factor, ZFP57, during preimplantation development. Mislocalization
away from the nucleus and increased protein levels preceded a decrease in protein
enrichment at five imprinted domains, Snrpn, Kcnq1ot1, Peg3, Peg1 and H19, proposing
a possible mechanism for imprint methylation maintenance loss following ARTs. Data
presented in this thesis suggest that infertility can predispose the oocyte to imprinting
errors, but imprint acquisition is a relatively robust process and is unaffected by ARTs.
Instead, superovulation disrupts one or more key maternal effects factors, including
ZFP57, necessary for imprint maintenance during early embryogenesis. Future studies
defining additional factors involved in the regulation of genomic imprinting, and
improving current ARTs techniques to minimize effects on this pathway, will lead to a
reduced incidence of disease in children born under impaired fertility and through
assisted reproduction.
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1
1 CHAPTER 1: Introduction
1.1

Epigenetics

1.1.1 Introduction to Epigenetics
The science of epigenetics has transformed over the last three quarters of a
century from an intriguing phenomenon to a modern field of research. First termed by
C.H. Waddington in 1942 for the study of causal mechanisms of development
(Waddington 2012), epigenetics is now defined as the study of heritable and reversible
chromatin modifications that alter the accessibility of genes and regulate gene expression
(Jaenisch & Bird 2003, Rodenhiser & Mann 2006). From the combination of the word
“genetics” and the prefix “epi”, meaning “above”, epigenetics encompasses alterations in
gene function that are not brought about by conventional changes to the DNA sequence.
Rather, these modifications reflect the interactions between genetic processes and their
external environment, altering the “readability” of the genetic information. The
mechanisms that regulate gene activation or repression are essential for development and
differentiation, known as epigenetic programming; a similar concept to the “epigenetic
landscape” originally described by Waddington (Waddington 2006).
1.1.2 Mechanisms of Epigenetic Regulation
Knowledge of epigenetic regulation continues to evolve as our understanding of
its mechanisms expands. DNA methylation, histone modifications, and long non-coding
RNAs all contribute to changes in chromatin structure and accessibility of the genetic
material (Figure 1-1). These mechanisms play important roles in the establishment of
epigenetic programming during gamete and embryo development.
1.1.2.1 DNA Methylation
DNA methylation is the covalent addition of a methyl group onto the C5 position
of cytosine residues in CpG dinucleotides. It is typically associated with gene silencing.
DNA methyltransferase enzymes DNMT3A, DNMT3B, along with DNMT3L, act as de
novo methyltransferases establishing DNA methylation at unmethylated CpGs.
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Figure 1- 1 Mechanisms of Epigenetic Regulation
The nucleosome consists of DNA (blue line) wrapped twice around an octamer of
core histone proteins; H2A, H2B, H3 and H4, with H1 or H5 as linkers. In active
domains, the most common histone modifications applied to histone tails (black wavy
lines) include acetylation (eg. H3K9Ac, green circle), methylation (eg. H3K4Me, yellow
hexagon) and phosphorylation (eg. H3S10P, red triangle). There is typically no DNA
methylation at CpG dinucleotides in an active domain (white circles on DNA strands).
Long non-coding RNAs (light orange wavy lines) act in cis or trans to promote gene
activation, act as scaffolds, or promote chromatin changes. In repressed domains,
nucleosomes are tightly compacted. The most common histone modification is
methylation (eg. H3K9Me and H3K27Me, yellow hexagons), along with the presence of
DNA methylation (black circles on DNA strands). Long non-coding RNAs (dark orange
wavy line) act in cis or trans to suppress gene expression, act as scaffolds, or promote
chromatin changes.
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By comparison, DNMT1 is responsible for maintaining DNA methylation through
its recognition of hemi-methylated DNA, resulting in heritable DNA methylation through
successive rounds of DNA replication by adding a methyl group to the daughter strand.
Upon the absence of maintenance DNMT1 activity, the act of passive DNA
demethylation results in lower levels of DNA methylation following each round of
replication. By comparison, the act of active DNA demethylation remained unclear until
the discovery of the TET (ten-eleven translocation) family of DNA dioxygenases. The
enzymatic oxidation by TET enzymes convert 5-methylcytosine (5mC) into 5hydroxymethylcytosine (5hmC), and further into 5-formylcytosine (5fC) and 5carboxylcytosine (5caC), completing the reversion from 5caC to unmethylated cytosine
(C) through passive loss (Gu et al. 2011, Inoue et al. 2011, Inoue & Zhang 2011).
1.1.2.2 Histone Modifications
The basic chromatin unit is the nucleosome, containing double-stranded DNA
wrapped around an octamer of core histone proteins, two each of H2A, H2B, H3 and H4.
Histones H1 or H5 act as linkers (Campos & Reinberg 2009). Chromatin is a dynamic
structure that undergoes alterations in its packaging, affecting the accessibility of
underlying genes (Bannister & Kouzarides 2011). Heterochromatin is a highly condensed
structure that results in gene silencing, while euchromatin is a less compacted
configuration supporting gene expression. Switching between active and repressive
chromatin states is facilitated by covalent post-translational modifications of histone tails
(Bannister & Kouzarides 2011). Histone tail modifications confer either activating or
silencing functions, depending on the type of modification and the amino acid residue
that is modified. A more active and open chromatin state occurs by acetylation of lysine
residues and phosphorylation of serine and threonine residues, examples being H3K9Ac
and H3S10P (Mahadevan et al. 1991, Schiltz et al. 1999). In comparison, modifications
such as methylation, ubiquitination, and sumoylation can promote either an open or
closed chromatin state depending on their location along the histone tail. For example,
methylation at H3K4Me is characteristic of an active state, while H3K9Me and
H3K27Me promotes a repressive conformation. Histone methylation can be present in
mono-, di-, or tri- forms on both lysine and arginine residues. A potential for chromatin
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bivalency in the early embryo, where both activating and repressive marks occupy the
same stretch of chromatin, is likely a major factor in establishing the correct gene
expression profile for embryonic development (Schultz 2002).
1.1.2.3 Long Non-coding RNAs
Owing to novel technologies including tiling arrays and genome-wide cDNA
sequencing, it has been revealed that only 1% of the mammalian genome carries proteincoding genes, and in fact the majority of the mammalian transcriptome is comprised of
non-coding RNAs (Lee 2012). These non-coding RNAs have been recognized as key
players in epigenetic regulation, chromatin remodeling, and alternative mRNA
processing (Kuramochi-Miyagawa et al. 2008, Guttman et al. 2009, Khalil et al. 2009).
Long non-coding RNAs (lncRNAs) are defined as RNAs greater than 100
nucleotides in length. They can be found in intronic, intragenic, or intergenic regions
along the genome. These regulatory transcripts can be cis-acting or trans-acting, can be
in a sense or antisense orientation, and can positively or negatively modify expression of
their protein coding or non-coding target genes (Dinger et al. 2008), including
suppression of transcriptional processes by transcriptional interference. Finally, they are
reported to act as scaffolds, recruiting chromatin modifying complexes to specific loci to
enable repressive or activating histone modifications (Mancini-Dinardo et al. 2006, Rinn
et al. 2007).
The best-known functional lncRNAs are involved in X chromosome inactivation,
an epigenetic dosage-compensation mechanism in female mammals. The inactive Xspecific transcript (Xist) lncRNA is expressed from the inactive X chromosome only, and
is essential for silencing the entire chromosome (Wutz 2011). The X (inactive)-specific
transcript, opposite strand (Tsix), determines allelic choice by repressing Xist
transcription on the active X chromosome (Lee et al. 1999, Lee & Lu 1999).
Interestingly, the number of lncRNAs within the genome of an organism increases with
its morphological complexity (Amaral & Mattick 2008). Many show significant
evolutionary conservation (Guttman et al. 2009), as well as distinct cell type specific and
developmental stage specific expression profiles (Dinger et al. 2008), supporting their
functional role in the regulation of key physiological processes (Koerner et al. 2009).
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1.2

Genomic Imprinting

1.2.1 Introduction to Genomic Imprinting
First termed by H. V. Crouse in 1960, an “imprint” was described as a mark that a
chromosome harboured independent of its genetic information, but rather on the gameticorigin through which it had been inherited (Crouse 1960). This functional nonequivalence of the parental genomes was later demonstrated through elegant nuclear
transplantation studies in the mouse. Specifically, zygotes containing two sets of maternal
chromosomes (gynogenotes) result in mid-gestation conceptuses with apparent
embryonic tissues but underdeveloped extraembryonic (placental) tissues. Zygotes
containing two sets of paternal chromosomes (androgenotes) show opposite results,
having placental tissues present but lacking embryonic tissue development. In both
uniparental conditions, embryos fail to grow beyond mid-gestation (Barton et al. 1984,
McGrath & Solter 1984). The authors concluded that both maternal and paternal
contributions are necessary for normal mammalian development, and suggested the term
“genomic imprinting” for the process that makes the two pronuclei functionally different
(Surani et al. 1984). The use of mouse models carrying two copies of a chromosome pair
or part of a chromosome from a single parent, termed uniparental disomy (UPD), show
that these parental-specific effects map to specific genomic regions (Cattanach & Kirk
1985). These studies confirmed that imprinted genes expressed only from one of the two
inherited chromosomes are important and necessary for early mammalian development.
Genomic imprinting is now defined as a specialized epigenetic mechanism that
employs repressive modifications to silence one parental allele and activating
modifications on the other parental allele to enable expression (Hirasawa & Feil 2010)
(Figure 1-2). These imprinted genes often reside within domains, coordinately regulated
in cis by a DNA element within the differentially methylated region (DMR) known as the
imprinting center, or imprinting control region (ICR). To be classified as an ICR, the
differentially methylated region must be deleted, either spontaneously or experimentally,
resulting in loss of imprinting (Spahn & Barlow 2003). Germ line differentially
methylated regions and ICRs acquire DNA methylation in the gametes and are faithfully
maintained through development.
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Figure 1- 2 Genomic Imprinting
Biallelic expression (green bars) from both the maternal and paternal alleles is
characteristic of most genes in the genome. A small subset of genes are expressed in a
monoallelic, parental-specific manner. Some are expressed from the maternally inherited
active allele (red bar), and are repressed on the paternally inherited silent allele (grey bar
with black circles representing DNA methylation), while oppositely, others are expressed
from the paternally inherited active allele (blue bar) and repressed on the maternally
inherited silent allele (grey bar with black circles representing DNA methylation).
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1.2.2 Imprinted Domains of Interest
There are approximately 150 imprinted genes identified to date (Morison et al.
2005) (http://www.mousebook.org/catalog.php?catalog=imprinting). Of these, the five
domains below are commonly used for genomic imprinting studies.
1.2.2.1 The H19 Imprinted Domain
The H19 domain, one of the first imprinted domains to be discovered (Bartolomei
et al. 1991), is located on human chromosome 11p15.5 and mouse chromosome 7. H19 is
a long non-coding RNA expressed from the maternal allele and silent on the paternal
allele. Insulin-like growth factor 2 (Igf2), a second gene within the domain, is a proteincoding gene oppositely expressed from the paternal allele and silent on the maternal
allele. Located downstream of H19 are enhancer elements, and upstream of H19 is an
imprinting control region (ICR) (Srivastava et al. 2000). The H19 ICR acquires DNA
methylation during spermatogenesis and is unmethylated in oocytes, resulting in a
methylated paternal allele and an unmethylated maternal allele in embryos/offspring.
Regulation of the H19 imprinted domain results from an enhancer-insulator model
(Figure 1-3). On the maternal unmethylated allele, the insulator protein CTCF binds to
the CpG island forming an intrachromosomal loop. This brings the H19 promoter in close
proximity to the enhancer elements, enabling transcription. At the same time, this
insulator action prevents interaction of Igf2 and the enhancer elements, resulting in
silencing (Hark et al. 2000, Li et al. 2008a). On the paternal allele, DNA methylation at
the ICR prevents CTCF binding, enabling a chromatin confirmation that supports
interaction between Igf2 and the enhancers, promoting transcription. DNA methylation at
the ICR expands into the H19 promoter DMR and effectively represses H19 expression
(Srivastava et al. 2000, Kaffer et al. 2001).
The H19 domain has been implicated in the overgrowth disorder BeckwithWiedemann Syndrome (BWS) (Shuman et al. 1993). This disorder is characterized by
macroglossia, neonatal hypoglycemia, abdominal wall defects, and postnatal growth
above the ninetieth percentile (Elliott et al. 1994). There is also an increased incidence of
Wilm’s tumor in these patients (Shuman et al. 1993).
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Figure 1- 3 The H19 Imprinted Domain
The H19 imprinted domain undergoes genomic imprint regulation through an
insulator/enhancer model. Top and bottom strands correspond to maternal and paternal
alleles, respectively. The maternal allele is unmethylated at the imprinting control center
(ICR), allowing the insulator protein CTCF (orange pentagon) to bind. CTCF interacts
with the ICR and the unmethylated DMR1 generating a looping structure. This prevents
the interaction of the enhancer elements (E; green boxes) with the upstream Igf2 gene
promoter resulting in repression, but allows for interaction with the H19 promoter
resulting in expression (red box). On the paternal allele, DNA methylation (black circles)
of the ICR represses H19 expression and prevents binding of CTCF, generating an
alternative looping structure with the methylated DMR2 that allows the enhancer
elements to interact with the Igf2 promoter, resulting in expression (blue box). Errors in
the H19 domain have been reported to associate with both Beckwith-Wiedemann
Syndrome and Silver-Russell Syndrome.
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An estimated 5% of BWS patients result from a gain of DNA methylation
(hypermethylation) imprinting defect at the maternal H19 ICR, causing biallelic silencing
of H19 and overexpression of IGF2 (Sparago et al. 2004, Prawitt et al. 2005).
Interestingly, H19 is also implicated in a second imprinting disorder, Silver-Russell
Syndrome (SRS). DNA hypomethylation of the H19 domain occurs in up to 44% of these
cases (Eggermann et al. 2010). SRS is further discussed in the Peg1 section below.
1.2.2.2 The Kcnq1ot1 Imprinted Domain
The KCNQ1 overlapping transcript 1 (Kcnq1ot1) imprinted domain is situated in
close proximity to the H19 domain, and is located on human chromosome 11p15 and on
mouse chromosome 7. The Kcnq1ot1 ICR acquires gametic DNA methylation in the
oocyte and is unmethylated in sperm. Thus, embryos/offspring possess a methylated
maternally-inherited allele and unmethylated paternally-inherited allele. Kcnq1ot1 is a
long non-coding RNA involved in imprinted regulation of the entire domain. Its promoter
is embedded in the ICR and consequently its imprinted pattern corresponds accordingly;
maternally repressed and paternally expressed (Mancini-DiNardo et al. 2003, Pandey et
al. 2004) (Figure 1-4). On the paternal allele, the Kcnq1ot1 ICR is unmethylated,
allowing expression of the Kcnq1ot1 lncRNA, which in turn represses all imprinted genes
within the domain. A study published from my research group indicates that transcription
of Kcnq1ot1 extends 471 kb in length on the paternal allele (Golding et al. 2011). This
results in repression of all other imprinted genes within the domain. Controversy exists
within the field as to whether the act of Kcnq1ot1 transcription through the domain
creates transcriptional interference of downstream genes or whether the lncRNA itself
plays a post-transcriptional role in coating the domain, similar to that of Xist on the X
chromosome. However, the study from my colleagues supports the former. RNAinterference technology via short hairpin RNA (shRNA)-mediated Kcnq1ot1 RNA
depletion in embryonic stem (ES), trophoblast stem (TS) and extra-embryonic endoderm
stem (XEN) cells shows no observable effect on the imprint status of the surrounding
genes in the domain (Golding et al. 2011). By comparison, DNA methylation on the
maternal ICR results in repression of Kcnq1ot1 and allows tissue-specific expression of
all other imprinted genes within the domain.
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Figure 1- 4 The Kcnq1ot1 Imprinted Domain
The Kcnq1ot1 imprinted domain is regulated through long non-coding RNA
mediated silencing. Top and bottom strands correspond to maternal and paternal alleles,
respectively. On the paternal allele, the ICR is unmethylated, allowing expression of the
lncRNA Kcnq1ot1 (blue wavy line). This in turn represses all imprinted genes within the
domain (grey boxes). On the maternal allele, the Kcnq1ot1 ICR is methylated, preventing
expression of Kcnq1ot1 and facilitating an active domain where all other imprinted genes
are expressed (red boxes; maternal expression in embryo and placenta, pink boxes;
maternal expression in placenta). Errors in the Kcnq1ot1 domain give rise to BeckwithWiedemann Syndrome.
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Like the H19 imprinted domain, misregulation of the Kcnq1ot1 imprinted domain
occurs in patients with Beckwith-Wiedemann Syndrome (Weksberg et al. 2001,
Weksberg et al. 2005). Loss of DNA methylation on the maternal KCNQ1OT1 ICR
occurs in 50% of BWS patients, causing biallelic expression of the KCNQ1OT1 lncRNA
and biallelic silencing of the maternally expressed genes, including potassium voltagegated channel, KQT-like subfamily, member 1 (KCNQ1) and cyclin-dependent kinase
inhibitor 1C (CDKN1C) (Horike et al. 2000, Weksberg et al. 2001, Niemitz et al. 2004).
1.2.2.3 The Snrpn Imprinted Domain
The small nuclear ribonucleoprotein N (Snrpn) imprinted domain is located on
human chromosome 15q11-13 and mouse chromosome 7. The ICR is embedded within
the promoter and first exon of Snrpn. It has a maternal specific DNA methylation mark
acquired in the oocytes, and is unmethylated in sperm (Shemer et al. 1997). On the
paternal allele, the unmethylated Snrpn ICR facilitates transcription of a long non-coding
RNA, Snrpnlt (Ube3a-as), which directs expression of the other paternally expressed
genes and silences the maternally expressed ubiquitin protein ligase E3A (Ube3a) and
ATPase, class V, type 10A (Atp10a) genes (Figure 1-5). Conversely, DNA methylation
at the ICR on the maternal allele prevents transcription of Snrpnlt and enables Ube3a and
Atp10a expression (Horsthemke & Wagstaff 2008).
The SNRPN imprinted domain is implicated in two neurological imprinting
disorders, Angelman Syndrome (AS) and Prader-Willi Syndrome (PWS). Angelman
Syndrome is represented by ataxia, severe mental and motor retardation with absence of
speech, aggressive behaviour, excessive inappropriate laughter and seizures (Nicholls et
al. 1998, Jiang et al. 1999, Nicholls & Knepper 2001). Prader-Willi Syndrome is
characterized by hypotonia and failure to thrive in the neonatal period, respiratory
distress, hyperphagia leading to obesity, hypogonadism, short stature, and behavioural
problems associated with mental retardation (Butler 1990, Nicholls et al. 1998, Nicholls
& Knepper 2001). Up to 70% of patients harbour large deletions in the SNRPN imprinted
region (Horsthemke 1997). Uniparental disomy (Nicholls et al. 1989) and imprinting
defects (Buiting et al. 1990) account for the other portion of these cases.
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Figure 1- 5 The Snrpn Imprinted Domain
The Snrpn imprinted domain is regulated by a bipartite ICR. Top and bottom
strands correspond to maternal and paternal alleles, respectively. The AS-IC promotes
expression of the maternally expressed genes (red boxes). Loss of maternal DNA
methylation and loss of expression of the maternally expressed genes result in Angelman
Syndrome. The PWS-IC is involved in expression of the paternally expressed genes (blue
boxes), like Snrpn. Gain of paternal DNA methylation and loss of expression on the
paternally expressed genes result in Prader-Willi Syndrome.
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Two distinct regions in the SNRPN ICR have been identified through
microdeletions, characterizing it as a bipartite ICR (Horsthemke 1997). The centromeric
component is involved in promoting expression of UBE3A and ATP10A (AS-IC) on the
maternal allele. AS is caused by loss of function of these normally maternally expressed
genes via paternal UPD, deletion of the AS-IC, or loss of DNA methylation at the
SNRPN ICR. One causative factor identified in the development of Angelman Syndrome
is silencing of UBE3A, an enzyme involved in the ubiquitin protein degradation system in
the brain (Horsthemke & Wagstaff 2008). The telomeric component of the bipartite ICR
(PWS-IC) is involved in expression of paternally expressed 12 (PEG12/FRAT3) makorin
ring finger protein 3 (MKRN3), MAGE-like 2 (MAGEL2), necdin, melanoma antigen
family member (NDN), and SNRPN on the paternal allele alone (El-Maarri et al. 2001).
PWS is caused by loss of function of the paternally expressed genes and can occur
through maternal UPD, deletion of the PWS-IC, or gain of DNA methylation at the
SNRPN ICR.
1.2.2.4 The Peg1 Imprinted Domain
The paternally expressed gene 1 (Peg1, also known as Mest) imprinted domain is
located on human chromosome 7q32 and mouse chromosome 6. A Peg1 ICR has not yet
been molecularly delineated, but the known DMR spanning the Peg1 promoter acquires
its gametic DNA methylation mark in the oocyte. This results in a methylated maternal
allele and an unmethylated paternal allele in embryos/offspring (Riesewijk et al. 1997,
Nishita et al. 1999). Also located in the domain are two maternally expressed genes,
Kruppel-like factor 14 (Klf14) and coatomer protein complex, subunit gamma 2 (Copg2),
and a paternally expressed gene, Copg2 opposite strand 2 (Mit1) (Figure 1-6). Regulation
of this domain remains largely unknown, although a study has shown that TRIM28 and
its interaction with HP1 are essential for maintaining repression on the methylated
maternal allele (Riclet et al. 2009). Maternal UPD harbouring the PEG1 imprinted
domain arises in 5% of Silver-Russell Syndrome patients (Kotzot et al. 1995, Eggermann
et al. 2010). SRS is an imprinting disorder characterized by intrauterine and post-natal
growth retardation (Wollmann et al. 1995), low birth weight, triangular shaped face and
body asymmetry (Silver et al. 1953, Russell 1954).
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Figure 1- 6 The Peg1 Imprinted Domain
The Peg1 imprinted domain. Top and bottom strands correspond to maternal and
paternal alleles, respectively. The Peg1 DMR is methylated on the maternal allele,
silencing Peg1 (also known as Mest) and enabling expression of Copg2 and Klf14 (red
boxes). On the paternal allele, the Peg1 DMR is unmethylated, enabling expression of
Peg1 (blue box) while Copg2 and Klf14 are silent. Imprinted genes are intersperced
among non-imprinted genes (green boxes) that are expressed from both parentally
inherited alleles. Silver-Russell Syndrome has been linked to imprinting errors at this
locus.
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1.2.2.5 The Peg3 Imprinted Domain
The paternally expressed gene 3 (Peg3) imprinted domain is situated on human
chromosome 19q13.4 and mouse chromosome 7. An identified ICR has not yet been
delineated, but the Peg3 DMR is differentially methylated in the gametes, acquiring DNA
methylation only in the oocytes while in sperm the Peg3 DMR is unmethylated. This
differential methylation is carried into adulthood (Li et al. 2000, Huang & Kim 2009). As
the ICR is embedded in the Peg3 promoter and first exon, Peg3 is silenced accordingly
on the maternal allele and expressed paternally (Figure 1-7). The transcriptional start site
of ubiquitin specific peptidase 29 (Usp29) lies close to that of Peg3 and is also paternally
expressed, along with zinc finger protein 264 (Zfp264) located further upstream. Zinc
finger imprinted 1, 2, and 3 (Zim1, Zim2, Zim3, respectively) are conversely maternally
expressed. To date, no human imprinting disorders has been linked to errors at this locus.
However, loss of paternal Peg3 expression in mice results in growth retardation, lower
metabolic rate, delayed development (Curley et al. 2005), increased apoptosis in the brain
(Broad et al. 2009), as well as aberrant maternal behaviour (Champagne et al. 2009).
1.2.3 Epigenetic Programming
Gamete and early embryo development are important stages when genome-wide
epigenetic transitions are orchestrated. During oogenesis and spermatogenesis, previous
somatic epigenetic modifications are erased, and new sex-specific epigenetic marks are
acquired (Hajkova et al. 2002, Kageyama et al. 2007). Paternal DNA methylation
acquisition occurs by DNMT3B/3L during prenatal stages of spermatogenesis and is
completed by birth (Saitou et al. 2012). During spermiogenesis, protamines replace the
majority of histones (Carrell 2012), and the resulting effect is tight compaction of
chromatin. Histone-containing chromatin, which is situated at spermatogenic,
developmental, microRNA and paternally expressed imprinted gene promoters, harbors
active histone modifications (H3Ac, H4Ac, and H3K4me2/3) or bivalency marks
(H3K4me3 and H3K27me3) and is hypomethylated, while that at maternally expressed
imprinted genes possess repressive modifications (H3K9me2/3 and DNA methylation)
(Hammoud et al. 2009, Brykczynska et al. 2010, Carrell 2012, Nakamura et al. 2012).
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Figure 1- 7 The Peg3 Imprinted Domain
The Peg3 imprinted domain. Top and bottom strands correspond to maternal and
paternal alleles, respectively. The Peg3 imprinted domain is methylated at the DMR on
the maternal allele, silencing genes nearby, like Peg3 and the APeg3 lncRNA, but
enabling expression of periphery genes (red boxes). On the paternal allele, the DMR is
unmethylated, enabling expression of nearby genes (blue boxes) and the APeg3 lncRNA
(blue wavy line). No human imprinting disorder has been linked to errors at this locus,
but some characteristics coincide with known syndromes.
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During oogenesis, acquisition of maternal DNA methylation begins comparatively
later (puberty) in primary to antral stage follicles and is mostly complete in MII-ovulated
oocytes (Saitou et al. 2012). The MII oocyte genome also possesses repressive histone
modifications (H3K9me2/3 and H4K20me3) (Lepikhov et al. 2010, Hales et al. 2011)
(Figure 1-8).
Following fertilization, global epigenetic reprogramming occurs again with a
switch from a gamete-specific to embryonic state. The pronuclear paternal genome is
rapidly and actively demethylated by the enzymatic oxidation of TET3, undergoing
protamine to histone replacement, and further acquiring active histone modifications
(H4Ac, H3Ac, and H3K4me2/3) (Lepikhov et al. 2010, Hales et al. 2011). By
comparison, the maternal pronuclear genome contains active (H4Ac, H3Ac, and
H3K4me2/3) and repressive modifications (H3K9me2/3, H3K27me2/3, and H4K20me3)
and becomes passively demethylated during preimplantation development at each
replicative cycle in the absence of DNA methylation maintenance activity. By the fourcell stage, the paternal genome acquires repressive histone modifications (H3K9me2,
H3K27me2, and H3K27me3) and is globally no longer distinguishable from the maternal
genome (Hales et al. 2011). Thus, before and after fertilization, the paternal and maternal
genomes have acquired asymmetric epigenetic modifications.
The two parental genomes undergo extensive changes in global DNA methylation
during preimplantation development, and post-implantation, de novo DNA methylation
gradually increases in accordance with cellular differentiation (Monk et al. 1987). DNA
methylation at imprinting domains is excluded from the global DNA methylation events
during preimplantation development; the ICR of the methylated allele remains
methylated and protected from demethylation, while the unmethylated allele remains
unmethylated (Morgan et al. 2005). Maintenance of these methylation marks through
preimplantation development requires expression of DNMT1 (Howell et al. 2001, Cirio
et al. 2008, Hirasawa et al. 2008, Kurihara et al. 2008), as well as changes in histone
modifications, including H3K9me2 and H3K27me3 enrichment on the repressed allele
(Kim & Ogura 2009) and repressive proteins including DPPA3, ZFP57, and TRIM28
(discussed below) (Figure 1-9).
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Figure 1- 8 Epigenetic Landscape in the Gametes
In mature sperm, protamines tightly compact chromatin into toroids (90–99%
chromatin) that are punctuated by histone solenoids (1–10% chromatin). Sperm DNA is
hypermethylated (red; DNA me) except at regions bearing active and bivalent histone
modifications. By comparison, histones compact chromatin in the mature oocyte.
Chromatin is further condensed into loops that are bound to spindle fibers. Oocyte
chromatin is hypermethylated and carries repressive histone modifications (Denomme &
Mann 2012).
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Figure 1- 9 DNA Methylation Asymmetry
Paternal (blue line) and maternal (red line) DNA methylation is erased in
primordial germ cells. Acquisition of DNA methylation by de novo DNMTs (red and
orange circles) occurs earlier in male compared to female germ cell development.
Following fertilization, the paternal genome is rapidly and actively demethylated (light
blue line) while the maternal genome (light red line) is passively demethylated at each
replication cycle. Differential DNA methylation at imprinted genes is protected from
demethylation. DPPA3 (yellow circle) protects against active demethylation in the
zygote. ZFP57 (pink circle), TRIM28 (blue circle), and DNMT1 (purple circle) protect
against passive demethylation during preimplantation development. Infertility/subfertility
and various assisted reproductive technologies (ARTs) may cause epigenetic instability at
the erasure, acquisition, and maintenance stages (Denomme & Mann 2012)
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1.3

Programming of Genomic Imprinting

1.3.1 Maternal Effect Factors
During oocyte growth, transcripts from the maternal genome accumulate. While
most are translated into proteins by oocyte machinery, some are sequestered and remain
dormant until after fertilization (Racki & Richter 2006). The majority of maternal
transcripts (90%) are degraded within the zygote after completing their oogenic function.
However, a subset of maternal transcripts are required for early developmental
programming prior to embryonic gene activation (Sirard 2012). This pivotal event occurs
at the 2-cell stage in mice, 4-cell stage in humans and 8–16-cell stage in cattle (Bruce
2013). Thus, the health of the early preimplantation embryo is largely dependent on the
oocyte for many crucial aspects of embryonic development, requiring transcription
factors, pluripotency-enabling factors and chromatin remodelling factors, among many
others (Li et al. 2010). Since imprinted methylation marks must be maintained during the
oocyte-to-embryo transition, maternal-effect genes may also be expected to play a role in
genomic imprint regulation (Figure 1-9).
One of the first hypotheses proposing that maternal-effect factors play a role in
embryonic epigenetic regulation was by Marilyn Monk (Monk 1990). She postulated that
reduced levels of global DNA methylation in oocytes compared with that in spermatozoa
would permit increased expression of a repertoire of stored molecules needed to support
development after fertilization. In accordance with this hypothesis, high concentrations of
DNA methyltransferases present in the oocyte would ensure propagation of imprinted
methylation patterns during preimplantation development. In a second hypothesis of
‘mother knows best’ (Miri & Varmuza 2009), it was posited that the engulfing of the
maternal pronuclear chromatin by the nuclear membrane would generate a protective
shield around it, allowing selective transport of critical proteins. By comparison, the
paternal genome, which is bathed in ooplasm, would be exposed to oocyte remodeling
systems, permitting epigenetic transformation of the paternal genome.
Since these hypotheses were proposed, four maternal-effect proteins have been
identified that protect imprinted methylation sites during preimplantation development:
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(i) developmental pluripotency-associated 3 (DPPA3; also known as STELLA/PGC7)
(Nakamura et al. 2007); (ii) DNA methyltransferase 1 oocyte-specific isoform
(DNMT1o) (Hirasawa et al. 2008); (iii) zinc finger protein 57 (ZFP57) (Li et al. 2008b);
and (iv) tripartite motif-containing 28 protein (TRIM28, also known as KAP1/TIF1b)
(Messerschmidt et al. 2012).
1.3.1.1 The Maternal Effect Factor DPPA3
DPPA3 was first described as a primordial germ cell marker in the ovary and
testis (Goto et al. 2002). Although it is not required for germ cell specification in mice,
homozygous null females have reduced fertility because early embryos undergo
precocious compaction and fail to reach the blastocyst stage (Payer et al. 2003, Bortvin et
al. 2004). Thus, maternally supplied DPPA3 is important during cleavage stages of
preimplantation development. Embryonic gene activation from the paternal DPPA3 allele
at the 2-cell stage does not rescue the abnormalities resulting from maternal deletion.
This outcome indicates that a crucial function of DPPA3 must occur after fertilization but
before the 2-cell stage (Nakamura et al. 2007). During this time, the zygote undergoes
active demethylation of the paternal genome, whereby TET3 methylcytosine dioxygenase
oxidizes 5-methylcytosine (5mC) to 5-hydroxymethylcytosine (5hmC) (Nakamura et al.
2007, Nakamura et al. 2012). Zygotes lacking maternal DPPA3 actively demethylate
both the paternal and maternal genomes (Nakamura et al., 2007), demonstrating that
DPPA3 plays a role in protecting the maternal genome from active demethylation
following fertilization. This protection is mediated by DPPA3 binding to H3K9me2enriched nucleosomes to produce a change in chromatin structure, reducing TET3
chromatin affinity and thereby inhibiting 5mC conversion to 5hmC (Nakamura et al.,
2012). Thus, specificity is conferred by H3K9me2–DPPA3 interactions on the maternal
but not the paternal genome.
The effects on the whole genome brings into question how the paternal DNA
methylation at imprinted genes survive. The protective function of DPPA3 also extends
to imprinted genes harbouring H3K9me2 (Nakamura et al. 2012). These imprinted genes
include not only those with maternally inherited methylation (Peg1, Peg3, Peg10) but
also those with paternally inherited methylation (H19, Rasgrf1). In consequence, zygotes
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generated from DPPA3-null oocytes have significantly reduced DNA methylation levels
at imprinted genes (Nakamura et al. 2007). Thus, DPPA3 is a maternal-effect protein that
acts to protect the maternal genome, as well as imprinted genes inherited from both
parents, from active demethylation in zygotes.
1.3.1.2 The Maternal Effect Factor DNMT1o
The DNA methyltransferase family catalyses both de novo and maintenance
methylation. DNA methyltransferase 3A (DNMT3A) and its accessory protein DNMT3L
are required for acquisition of DNA methylation at unmethylated cytosines in both male
and female germ lines (Bourc'his et al. 2001, Kaneda et al. 2004). By comparison,
DNMT1 preferentially recognizes and methylates hemimethylated DNA, maintaining
methylation at each replicative cycle, including at imprinted regions (Yoder et al. 1997).
Two DNMT1 isoforms are present in mature oocytes and preimplantation embryos:
oocyte-specific (DNMT1o) and somatic (DNMT1s) isoforms. DNMT1o accumulates to
high concentrations during oocyte growth (Bao et al. 2000) and is the abundant form
expressed in oocytes and preimplantation embryos (Mertineit et al. 1998). DNMT1o
displays an intriguing localization pattern during preimplantation development. While
predominantly cytoplasmic, it transiently localizes to the nucleus at the 8-cell stage
(Howell et al. 2001), although this localization pattern is controversial (Hirasawa et al.
2008, Kurihara et al. 2008). Maternal- and embryonic-derived DNMT1s is also present in
preimplantation embryos, albeit at much lower concentrations than DNMT1o (Cirio et al.
2008, Kurihara et al. 2008). Both forms of DNMT1 play a role in protecting imprinted
genes from passive demethylation. DNMT1o functions as a maternal-effect protein, since
DNMT1o deficiency does not affect methylation acquisition in the oocyte, but instead
produces loss of imprinted methylation in mutant embryos derived from Dnmt1o-null
oocytes (Howell et al. 2001, Cirio et al. 2008). For the insulin-like growth factor 2
receptor (Igf2r) imprinted gene, methylation loss occurred in 8-cell, morula, and
blastocyst but not 4-cell mutant embryos. Analysis of morula, day-7.5 and day-9.5 mutant
embryos also showed Snrpn and H19 DNA methylation loss with variable levels of
methylation loss among embryos (Howell et al. 2001, Cirio et al. 2008). Depletion of
maternal DNMT1s via microinjection of oocytes with anti-DNMT1s antibody similarly
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produced a partial loss of H19 imprinted methylation in morula (Kurihara et al. 2008).
Deficiency of maternal DNMT1o and 1s also caused a partial loss of H19, Rasgrf1, Peg3
and Snrpn DNA methylation at the blastocyst stage (Hirasawa et al. 2008). These results
indicate that loss of maternal DNMT1o and/or DNMT1s produces a partial loss of
imprinted methylation. By comparison, lack of maternal + embryonic DNMT1 generated
complete demethylation of the H19, Rasgrf1, Peg3 and Snrpn ICR in blastocysts
(Hirasawa et al. 2008). Thus, maternal and embryonic DNMT1 provide protection from
preimplantation passive demethylation, which occurs in part by selective targeting of
DNMT1 to imprinted regions through ZFP57 hexanucleotide binding and TRIM28
repressive complex recruitment (Quenneville et al. 2011).
1.3.1.3 The Maternal Effect Factor ZFP57
P

,a

r ppel-associated box (KRAB) domain-containing zinc finger protein

originally identified as a marker of undifferentiated mouse embryonic stem cells
(Okazaki et al. 1994), is an essential maternal–embryonic-effect gene required for
effective imprint maintenance during preimplantation development. Functionally, ZFP57
plays a role in gene repression by binding to methylated DNA at the hexanucleotide
motif, TGCCGC (Quenneville et al. 2011). This hexanucleotide is present in mouse and
human DMRs. During preimplantation development, maternally derived ZFP57 is likely
the sole source of this protein. According to expression arrays, embryonic Zfp57
transcription does not begin until at least the blastocyst stage (Zeng et al. 2004), a time at
which embryonic ZFP57 protein has been detected (Li et al. 2008b). Examination at
earlier stages is still required to determine when embryonic ZFP57 protein is first
produced. To untangle the roles of maternally derived and embryonically produced
ZFP57 protein, targeted deletion and mating strategies were engineered to obtain
maternal, embryonic or maternal + embryonic deficiencies. Deletion of maternal +
embryonic ZFP57 resulted in embryonic lethality (Li et al. 2008b). While ablating
embryonic ZFP57 produced partial neonatal lethality, maternal ZFP57 deletion was not
lethal due to rescue by embryonic ZFP57. With respect to imprinted gene regulation,
mid-gestation embryos with loss of maternal + embryonic ZFP57 failed to maintain DNA
methylation at multiple maternally methylated DMRs (Snrpn, Peg1, Peg3, Peg5) as well
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as at the paternally methylated Gtl2 ICR (Li et al. 2008b). Embryos with maternal ZFP57
deficiency exhibited hypomethylation of Snrpn at day 3.5, but methylation levels were
rescued at day 13.5 by embryonic ZFP57. By comparison, embryos with an embryonic
ZFP57 mutation experienced a partial loss of DNA methylation that varied among
embryos (Li et al. 2008b). In humans, embryonic ZFP57 mutations also affected DNA
methylation at several imprinted regions (PLAGL1, GRB10, PEG3) (Mackay et al. 2008).
As stated, ZFP57 binds to its methylated hexanucleotide recognition site in imprinted
genes (Quenneville et al. 2011), and therefore may contribute to the imprinting errors
observed in infertility and ARTs patients.
1.3.1.4 The Maternal Effect Factor TRIM28
TRIM28 is a central element in a heterochromatin-inducing macromolecular
complex that was recently shown to protect imprinted regions from demethylation.
TRIM28 recruits heterochromatin protein 1 (HP1), DNMT1 and the H3K9me3catalyzing histone methyltransferase SETDB1, among others (Schultz et al. 2001,
Schultz et al. 2002, Iyengar & Farnham 2011). The specificity of this complex is
achieved through TRIM28 interactions with KRAB zinc finger proteins (Schultz et al.
2001, Schultz et al. 2002), a role taken by ZFP57 in imprinted genes, in which repression
occurs via ZFP57–TRIM28 interactions (Zuo et al. 2012). TRIM28 is a maternal-effect
protein (Messerschmidt et al. 2012), as indicated by the partial embryonic lethality
resulting from maternal TRIM28 deficiency. In mid-gestation Trim28 maternal mutant
embryos, loss of imprinted methylation is observed at the H19, Snrpn and Gtl2 ICRs,
which vary between embryos (Messerschmidt et al. 2012). Although embryonic TRIM28
activation occurs at the 2-cell stage with the protein appearing at the 4-cell stage, H19
imprinted methylation is still lost in 4- and 8-cell Trim28 maternal mutant embryos,
demonstrating a role for maternal TRIM28 in protection from passive demethylation.
Overall, these studies indicate that epigenetic reprogramming within the
preimplantation embryo necessitates the recruitment of specialized maintenance
complexes to imprinted regions to ensure epigenetic integrity, both directly after
fertilization and throughout cleavage-stage development. Misregulation of this pathway
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may explain loss of imprinting regulation among those with infertility and following
assisted reproduction.
1.4

Infertility and Assisted Reproduction

1.4.1 Introduction to Infertility
Worldwide, approximately 1 in 6 couples experience some form of impaired
fertility (Wright et al. 2005, Sunderam et al. 2009), defined as an inability to conceive
after one full year of regular unprotected sexual intercourse, and reduced to half a year
for women above 35 years of age. Infertility/subfertility can arise from an array of
genetic, epigenetic, endocrine, environmental, and physical factors. Treatment for
impaired fertility encompasses the use of assisted reproductive technologies (ARTs).
1.4.2 Female Infertility and Genomic Imprinting
The most common variable influencing natural conception in modern society is
reproductive age. Advanced maternal age (>35 years) is directly related to a decline in
female fecundity with a reduced oocyte reserve and poor oocyte quality (Liu & Case
2011). This leads to a plethora of embryonic issues including compromised embryo
quality, reduced blastocyst formation and expansion rate (Janny & Menezo 1996), poor
implantation efficiency and an increase in spontaneous abortion rates (Menken et al.
1986). The decline arises from chromosomal abnormalities, deviation in levels of
maternal-effect factors from the oocyte, and altered patterns of gene expression, among
others (Janny & Menezo 1996).
An increased incidence of imprinting disorders, like Beckwith-Wiedemann
Syndrome (BWS) and Angelman Syndrome (AS) in the ARTs population leads to the
question of whether infertility predisposes embryos to imprinting errors. An examination
of 16 AS children born to subfertile couples found 4 to arise by sporadic imprinting
defects, including 2 from couples without assisted reproduction (Ludwig et al. 2005). In
addition, a case of two BWS children in the same family, one born via ARTs and the
other born naturally, suggests that impaired fertility may be associated with mechanisms
leading to imprinting disorders (Strawn et al. 2010).

26
A Dutch study evaluating ARTs and parental infertility reported the same relative
risk of AS and BWS in subfertile couples with and without ARTs (Doornbos et al. 2007),
indicating that the increased prevalence of imprinting disorders can be explained by
compromised fertility. Significantly, advanced maternal age is more frequent in these AS
and BWS mothers compared to the general population, suggesting that advanced
maternal age may decrease fertility and increase the risk of imprinting disorders.
Barriers to a thorough evaluation of human infertility exist, including the ethical
and social issues involved in using human oocytes and embryos. Thus, validating a link
between female infertility and genomic imprinting is proven difficult. Similar to studies
on ARTs techniques, animal models can assist in addressing this issue. The mouse is
advocated as the model system of choice for studies of early embryo development and its
molecular regulation (Quinn & Horstman 1998, Summers & Biggers 2003). In mouse,
advanced maternal age compromises post-implantation development, although agerelated change in imprinted DNA methylation is not detected at Snrpn, Kcnq1ot1, Peg1,
H19, Igf2r, and zinc finger (CCCH type), RNA binding motif and serine/arginine rich 1
(Zrsr1) in blastocysts and mid-gestation conceptuses (Lopes et al. 2009). As imprints are
acquired during oocyte growth, studies are required to determine how genomic
imprinting acquisition in the oocyte changes under female infertility conditions. A
complex endocrine signaling pathway is active in the ovary regulating follicle and oocyte
development (Drummond & Fuller 2012). In addition, it is known that development of
healthy oocytes is dependent on interactions between the growing oocyte and
surrounding follicular cells (Kidder & Vanderhyden 2010). Compromised female fertility
through an impaired endocrine pathway and/or disrupted intercellular communication
may lead to a molecular mechanism causing imprinting acquisition errors in the infertile
population.
1.4.3 Introduction to Assisted Reproductive Technologies
Owing to the pioneering work of R. G. Edwards and the first assisted conception
in 1978, it is estimated that assisted reproductive technologies (ARTs) has enabled the
birth of ~5 million children worldwide from couples with infertility/subfertility
(International Committee for Monitoring Assisted Reproductive Technologies). ARTs
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encompasses any treatment modality that is used to improve fertility and establish a
pregnancy, including ovarian stimulation (superovulation), in vitro fertilization (IVF),
intracytoplasmic sperm injection (ICSI), and in vitro embryo culture (IVC) as well as the
experimental procedures such as in vitro oocyte maturation (IVM), and oocyte and
ovarian tissue cryopreservation. ARTs can lead to adverse prenatal and postnatal
outcomes, including increased risk of intrauterine growth restriction, premature birth, low
birth weight, congenital anomalies, and genomic imprinting syndromes (Savage et al.
2011). To reduce these risks, it is paramount to determine which aspects of treatment lead
to adverse effects so they may be modified for improved safety. Given that both impaired
fertility and ARTs alter the gamete and embryo environment and coincide with crucial
epigenetic events during those periods, epigenetic instability may be the primary
determinant of these suboptimal outcomes (Figure 1-9).
1.4.4 Imprinting Syndromes and Assisted Reproductive Technologies
Disruptions in the asymmetric parental states during gametogenesis and/or
embryogenesis can have severe consequences for growth and development. Of
significance is that many imprinted genes play critical roles in the development of the
embryo, and their misregulation is linked to the development of human imprinting
disorders, including Angelman Syndrome and Beckwith-Wiedemann Syndrome
(Hirasawa & Feil 2010). While generally healthy, evidence indicates that children
conceived by assisted reproduction may be at increased risk for imprinting errors and the
development of these rare genomic imprinting disorders (Denomme & Mann 2012). The
concern with ARTs is that the timing of these procedures coincides with crucial
epigenetic reprogramming events in gametes and early embryos, leading to their possible
disruption. This concern prompts the investigation of many procedures to determine their
effects on imprinted gene regulation (Denomme & Mann 2012).
An increased incidence of the human imprinting disorders AS and BWS with the
use of ARTs is observed (Cox et al. 2002, DeBaun et al. 2003, Gicquel et al. 2003,
Maher et al. 2003, Orstavik et al. 2003, Halliday et al. 2004, Ludwig et al. 2005,
Rossignol et al. 2006, Sutcliffe et al. 2006). More specifically, the incidence of AS in the
general population is approximately 1 in 16,000 births, with 5% of these cases related to
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imprinting abnormalities (Cox et al. 2002, Van Buggenhout & Fryns 2009). As the
prevalence of AS is low, large-scale studies containing sufficient numbers of patients is
difficult to achieve. However, seven cases of AS following the use of ARTs are reported
to date, five of which display imprinting abnormalities (Cox et al. 2002, Chang et al.
2005, Ludwig et al. 2005, Sutcliffe et al. 2006). This is a significantly higher proportion
in the ARTs-population compared with the non-ARTs population.
BWS is also reported in the ARTs population. This syndrome affects about 1 in
13,700 children (Weksberg et al. 2010). Parents of children with BWS are 4 to 9 times
more likely to have undergone fertility treatments than the general population, and a
higher incidence of BWS is seen in ART children compared with naturally-conceived
children (DeBaun et al. 2003, Gicquel et al. 2003, Maher et al. 2003, Halliday et al.
2004, Chang et al. 2005, Ludwig et al. 2005). Taken together, ARTs may impose
inherent risk for normal imprinted gene regulation resulting in imprinting disorders.
1.4.5 Ovarian Stimulation and Genomic Imprinting
To produce increased oocyte numbers for assisted reproduction, protocols
incorporate large gonadotropin doses. Ovarian stimulation, or superovulation, alone as a
fertility treatment can result in BWS and AS (Chang et al. 2005, Ludwig et al. 2005).
This leads to investigations of superovulation as a potential imprinting disruptor.
Individual mouse 16-cell embryos recovered from superovulated (7.5 IU eCG/hCG)
females have paternal H19 loss of DNA methylation in 2/10 embryos, maternal Snrpn
loss of DNA methylation in 2/10 embryos, and maternal H19 gain of DNA methylation
in 1/10 embryos. This frequency of imprinting errors is not statistically different from
controls. However, since only 12-24% of DNA strands per gene per embryo are
recovered, additional perturbations may be missed (El Hajj et al. 2011). Alternatively,
methylation perturbations may initiate at or after the 16-cell stage, since imprinted
methylation errors are present in blastocysts after superovulation. Following low (6.25 IU
eCG/hCG) and high (10 IU eCG/hCG) hormone regimes, a study from my research group
reports imprinted DNA methylation perturbations in individual mouse blastocysts at
maternal alleles of Snrpn (loss of DNA methylation in 4/10 low, 9/10 high blastocysts),
Peg3 (loss of DNA methylation in 4/9 low, 5/9 high blastocysts), Kcnq1ot1 (loss of DNA
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methylation in 2/6 low, 5/9 high blastocysts), and H19 (gain of DNA methylation in 1/10
low, 4/10 high blastocysts) (Market-Velker et al. 2010b). As paternal H19 loss of DNA
methylation is also seen (3/10 low, 7/10 high blastocysts), my colleagues concluded that
superovulation impairs both imprint acquisition in oocytes and imprint maintenance in
early embryos, in a dose-dependent manner. Moreover, multi-locus imprinted
methylation perturbations are greater in the high hormone group (10/10 blastocysts)
compared to the low hormone (4/10 blastocysts) and control groups (1/10 blastocysts).
Others have reported that at midgestation, mouse conceptuses produced via low hormone
(5 IU eCG/hCG) treatment show altered allelic expression of Snrpn, H19 and Igf2, but
not Kcnq1ot1 in placentas but not embryos (Fortier et al. 2008). Additionally, 3/8
superovulation-derived mice (5 IU eCG/hCG) show loss of DNA methylation at H19 and
Peg3, but not Snrpn, in brain and liver tissues (de Waal et al. 2012). These studies
indicate that superovulation can lead to imprinting maintenance errors.
As ovarian stimulation is administered during oogenesis, it may also disrupt
imprint acquisition. However, few studies have examined the effects of ovarian
stimulation on imprint acquisition in oocytes. Following low hormone treatment (5 IU
eCG/hCG), methylation of Snrpn, Peg3, Igf2r, and H19 is unaffected in mouse MII
oocyte pools (14-18 DNA strands analyzed per gene) (Anckaert et al. 2009a). These
results contrast with mouse oocytes collected after sequential hormone treatment (3 days
7.5 IU eCG/1 day 5 IU hCG) where H19 exhibits gain of DNA methylation (26-37%) in
pooled MII oocytes, although normal methylation acquisition is present at Peg1,
Kcnq1ot1 and pleiomorphic adenoma gene-like 1 (Plagl1/Zac1) (Sato et al. 2007). As
zona pellucidae are not removed from pooled oocytes, this H19 gain of DNA methylation
may be the result of cumulus cell contamination.
Following ovarian stimulation in humans, individual MI oocytes show PEG1 loss
of DNA methylation (2/7 oocytes) and H19 gain of DNA methylation (2/3 oocytes) (Sato
et al. 2007), and in the last study, pooled MII oocytes exhibit maternal KCNQ1OT1 loss
of DNA methylation (2/19 strands) (Khoueiry et al. 2008). With respect to the human MI
oocyte study, PEG1 may still be in its acquisition phase. Alternatively, human oocytes
may be more prone to epigenetic errors and/or encounter more stressors, such as multiple
hormone administration, advanced maternal age, and inherent infertility.
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Overall, the effect of superovulation on the establishment of maternal genomic
imprints in oocytes is still unresolved. Considering the frequency of epigenetic
perturbations in blastocysts compared to oocytes, ovarian stimulation may also have an
adverse impact on maternal-effect factors involved in imprint regulation.
1.5

Rationale
Gametogenesis and early embryogenesis are important stages when genome-wide

epigenetic transitions are orchestrated, including erasure, establishment and maintenance
of genomic imprinting. Changes from the normal maternal environment by inherent
infertility or the incorporation of assisted reproductive technologies may disrupt the
processes of imprint acquisition, imprint maintenance, and/or the factors required for
imprinting regulation. Furthermore, the discovery of maternal-effect genes has brought
new insights into the regulation of genomic imprinting. Understanding how an assisted
reproductive technology may disrupt those maternal-effect products that regulate
imprinting will be essential for maximizing the safety of assisted reproductive
technologies to ensure healthy embryonic development.
1.6

Hypothesis
My overall hypothesis is that maternal control of genomic imprinting is

compromised independently by impaired fertility and by ovarian stimulation.
Specifically, the process of imprint acquisition is disrupted in a maternal
infertility/subfertility model,

and imprint

acquisition is

also

disrupted upon

superovulation. Furthermore, I hypothesize that superovulation disrupts the function of
essential maternal-effect factors required for the regulation of genomic imprinting within
the critical periods of oocyte and preimplantation embryo development.
Importantly, the field of genomic imprinting has begun to adopt analyses at the
individual embryo level based on the stochastic nature of imprint loss between embryos
and between imprinted loci within each embryo. To undergo my objectives, it is
necessary to first modify the current bisulfite mutagenesis assay that facilitates analysis at
the individual blastocyst stage to enable analysis at the individual oocyte stage.
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1.7

Objectives
My objectives are as follows:

(1) Design a bisulfite mutagenesis assay to enable analysis of imprinted DNA
methylation at the individual oocyte level.
(2) Determine the effects of maternal subfertility and infertility on imprinted DNA
methylation acquisition in oocytes.
(3) Determine the effects of ovarian stimulation on imprinted DNA methylation
acquisition in oocytes.
(4) Determine the effects of ovarian stimulation on imprint regulation by the maternaleffect factor ZFP57.
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2 CHAPTER 2: Single Oocyte Bisulfite Mutagenesis Assay
The work in this chapter originates from the following peer-reviewed article:
Denomme MM, Zhang L, & Mann MRW (2012) Single oocyte bisulfite mutagenesis.
J. Vis. Exp. (64), e4046.

2.1

Introduction
Epigenetics encompasses all heritable and reversible modifications to chromatin

that alter gene accessibility, and thus are the primary mechanisms for regulating gene
transcription (Jaenisch & Bird 2003). DNA methylation is an epigenetic modification that
acts predominantly as a repressive mark. Through the covalent addition of a methyl group
onto cytosines in CpG dinucleotides, it can recruit additional repressive proteins and
histone modifications to initiate processes involved in condensing chromatin and
silencing genes (Rodenhiser & Mann 2006). DNA methylation is essential for normal
development as it plays a critical role in developmental programming, cell differentiation,
repression of retroviral elements, X-chromosome inactivation and genomic imprinting.
One of the most powerful methods for DNA methylation analysis is bisulfite
mutagenesis. Sodium bisulfite is a DNA mutagen that deaminates cytosines into uracils.
Following PCR amplification and sequencing, these conversion events are detected as
thymines. Methylated cytosines are protected from deamination and thus remain as
cytosines, enabling identification of DNA methylation at the individual nucleotide level
(Frommer et al. 1992). Development of the bisulfite mutagenesis assay has advanced
from those originally reported (Clark et al. 1994, Feil et al. 1994, Raizis et al. 1995)
towards ones that are more sensitive and reproducible (Patterson et al. 2011). One key
advancement was embedding smaller amounts of DNA in an agarose bead, thereby
protecting DNA from the harsh bisulfite treatment (Olek et al. 1996). This enabled
methylation analysis to be performed on pools of oocytes and blastocyst-stage embryos
(Mann et al. 2004). The most sophisticated bisulfite mutagenesis protocol to date is for
individual blastocyst-stage embryos (Market-Velker et al. 2010b). However, since
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blastocysts have on average 64 cells (containing 120-720 pg of genomic DNA), this
method is not efficacious for methylation studies on individual oocytes or cleavage-stage
embryos.
Taking clues from agarose embedding of minute DNA amounts including oocytes
(Meng et al. 2008), here we present a method whereby oocytes are directly embedded in
an agarose and lysis solution bead immediately following retrieval and removal of the
zona pellucida from the oocyte. This enables us to bypass the two main challenges of
single oocyte bisulfite mutagenesis: protecting a minute amount of DNA from
degradation, and subsequent loss during the numerous protocol steps. Importantly, as data
are obtained from single oocytes, the issue of PCR bias within pools is eliminated.
Furthermore, inadvertent cumulus cell contamination is detectable by this method since
any sample with more than one methylation pattern may be excluded from analysis
(Denomme et al. 2011). This protocol provides an improved method for successful and
reproducible analyses of DNA methylation at the single-cell level and is ideally suited for
individual oocytes as well as cleavage-stage embryos. The video component of this
article can be found at www.jove.com/video/4046/.
2.2

Protocol

DAY 1
Prepare the following solutions fresh on the day of oocyte collection with sterile,
distilled water such as GIBCO water. To reduce the chance of DNA contamination,
change gloves often and use filter tips. Keep tubes angled away when open, and recap all
tubes when not in use. We recommend that solutions are made as n+1.

3% LMP Agarose
30 mg Low Melting Point (LMP) Agarose
up to 1 mL GIBCO H2O
dissolve @ 70oC
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Lysis Solution
8 μl lysis buffer
1 μl proteinase
1 μl 10% IGEPAL
place on ice until ready for use
2:1 Agarose:Lysis Solution (10 μl per individual oocyte, amount is for 3 oocytes)
20 μl 3% LMP agarose
10 μl Lysis Solution
mix @ 70oC
SDS Lysis Buffer ( 01 μl per individual oocyte)
01 μl
1x TE pH 7.5
10% SDS
Proteinase K

4 0 μl
0 μl
1 μl

2.2.1 Oocyte Collection


Place the dissected mouse oviducts in M2 media, and tear the ampulae to extract
the cumulus cell complex



Separate the oocytes from the cumulus cell complex using 0.3 mg/mL
hyaluronidase solution in a 30 μl drop of M2 media.

eep the oocytes in solution

only as long as it takes to remove the cumulus cells, as lengthy exposure may
damage them. Wash the oocytes 3x in 30 μl drop of M2 media, removing cumulus
cells periodically.


Remove the zona pellucida using acidic tyrode’s solution. Place the oocytes in
one 30 μl drop of solution first, and then transfer to another 30 μl drop, as any
media carried along will dilute the acid and reduce its efficiency. Keep the
oocytes in solution only as long as it takes to remove the zona, as lengthy
exposure may damage them. Note: an increased concentration of acidic tyrode’s
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solution or pronase may be used for human samples, as the human zona pellucida
is more resistant to treatment with acidic tyrode’s solution than the mouse.


Wash the oocytes once more in a 30 μl drop of M2 media.

2.2.2 Agarose Embedding and Lysis


To perform agarose embedding, place the lysis solution on a 70oC heatblock. Add
the preheated LMP agarose to the lysis solution, producing a 2:1 agarose:lysis
solution.



Place a single oocyte onto a clean glass slide in minimal M2 media. Take up 10 μl
of the agarose:lysis solution into a pipette tip, and (under a microscope) gently
expel a small amount (~1 μl or less) onto the glass slide, allowing it to mix with
the minimal media. Gently pick up the oocyte into the pipette tip and put all 10 μl
into an eppendorf tube with 300 μl mineral oil so the bead forms a sphere. Note:
this process must be done fairly quickly as the agarose will harden if the
temperature drops as little as 5oC below 70oC.



Incubate the tube on ice for 10 minutes. To perform lysis, remove the 300 μl
mineral oil and add 00 μl of the SDS lysis buffer. Incubate overnight in a 0 oC
waterbath. Note: Lysis solution may also be used for this purpose.

DAY 2
Prepare the following solutions fresh on the day of bisulfite mutagenesis. To
reduce chance of DNA contamination, change gloves often and use filter tips. Keep tubes
angled away when open, and recap all tubes when not in use. We recommend that
solutions are made as n+1.

3 M NaOH

2.4 g NaOH in 20 mL autoclaved ddH2O

0.1 M NaOH

0.5 mL of 3M in 14.5 mL autoclaved ddH2O

0.3 M NaOH

1.5 mL of 3M in 13.5 mL autoclaved ddH2O
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2.5 M Bisulfite Solution
(a)

3.8 g sodium bisulfite
5.5 mL GIBCO distilled H2O
1 mL 3 M NaOH
dissolve @ room temperature

(b)

110 mg Hydroquinone
1 mL GIBCO distilled H2O
dissolve @ 90oC (for only as long as it takes to dissolve, mix regularly)

When fully dissolved, mix solution (a) and (b)
*Keep away from light*

2.2.3 Bisulfite Mutagenesis


ully remove the 00 μl SDS lysis buffer and add 300 μl mineral oil (~20 hours).
Any lysis buffer remaining will dilute the agarose when it is heated and the bead
will be more susceptible to dissolving in the subsequent steps. Proceed with
bisulfite mutagenesis immediately, or store at -20oC for up to 5 days.



If applicable, remove oocytes from the freezer and let thaw (only until agarose
bead is relatively translucent). Incubate for 2.5 minutes on a 90oC heat block,
following which Incubate on ice for 10 minutes. Note: Do not mix or stir, extend
longer than 2.5 minutes, or fluctuate temperature.



To perform denaturation, remove the mineral oil and add 1 mL 0.1M NaOH to
each tube, flick and invert 5-6 times.



Incubate for 15 minutes in a 37oC waterbath, inverting every 3-4 minutes. The
bead should float in the NaOH.



To perform bisulfite treatment, spin the tube gently, then remove the NaOH and
add 300 μl mineral oil and 00 μl bisulfite solution. Incubate the tube for 3.
hours in a 50oC waterbath. *Keep away from light* Note: Length of incubation
may need to be empirically determined for gene of interest.
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To perform desulfonation, incubate on ice for 3 minutes, then remove the mineral
oil and the bisulfite solution, spin gently, and add 1 mL 0.3 M NaOH. Flick and
invert 5-6 times.



Incubate for 15 minutes in a 37oC waterbath, inverting every 3-4 minutes. The
bead should float in the NaOH.



Wash the samples, by first spinning gently, then remove the NaOH and add 1 mL
1x TE pH 7.5. Shake for 5-10 minutes at room temperature (on a shaker). Spin
gently again, then remove the 1x TE. Repeat this washing process twice.



Add 1 mL autoclaved ddH2O. Shake for 5-10 minutes at room temperature (on a
shaker). Spin gently, then remove the H2O. Repeat ddH2O wash twice.



Check the pH of the supernatant; it should be pH 5.0. If still too basic, wash again
with H2O. Remove all supernatant, leaving only the agarose bead.

2.2.4 PCR amplification
Prepare 1st round PCR mix **while washing**
10 μM Primer orward Outer

0. μl

10 μM Primer Reverse Outer

0. μl

240 ng/mL tRNA

1 μl

H2O

13 μl

Add to Illustra Ready-to-Go Hot Start PCR beads
Carefully slide the solid agarose bead into the PCR tube (~10 μl)
Heat to 70oC and mix
Add 2 μl mineral oil
Total: 0 μl


Amplify. Note: An example of cycling conditions for mouse Snrpn is denaturation
for 2 minutes at 94oC, followed by 40 cycles of 30 seconds at 94oC, 1 minute at
50oC, and 1 minute at 68oC; and a final 10 minute elongation step at 68oC.
Annealing temperature for 1st round PCR for mouse H19 and Peg3 is 50oC.
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Prepare 2nd round PCR mix
10 μM Primer orward Inner

0. μl

10 μM Primer Reverse Inner

0. μl

H2O

19 μl

Add to Illustra Ready-to-Go Hot Start PCR beads
Add

μl 1st Round product as a template. Be sure to pipette below the layer of mineral

oil.
Add 2 μl mineral oil
Total: 0 μl
Note: Nested primer sequences for Snrpn, H19, and Peg3 can be found in (Market-Velker
et al. 2010b, Denomme et al. 2011).


Amplify. Note: Cycling conditions for mouse Snrpn is denaturation for 2 minutes
at 94oC, followed by 40 cycles of 30 seconds at 94oC, 1 minute at 50oC, and 1
minute at 68oC; and a final 10 minute elongation step at 68oC. Mouse H19 and
Peg3 require a 50oC annealing temperature for 2nd round PCR.



As a diagnostic test, second round samples can be cut with a restriction enzyme
that is methylation- or strain-specific.

2nd Round product

4 μl

Restriction Enzyme

1 μl

Buffer

1 μl

H2O

4 μl



Electrophorese the digestion products on an 8% acrylamide gel. Any
heterogeneous bands represent more than one sequence.

2.2.5 TA Cloning and Colony PCR


To clone 2nd round product, ligate into vector using the Promega pGEM-T
Vector System (Fisher Scientific Cat#A1360).
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2nd Round PCR

1 μl

pGEMT-EASY vector

1 μl

Ligase

1 μl

H2O

2 μl

2x Ligation Buffer

μl

Incubate overnight @ 4oC in PCR machine.


Thaw competent E.coli cells on ice for 15 minutes (Zymo Research Corp
Cat#T3009). Add 3 μl ligation reaction to 8 μl E.coli and incubate ligation on ice
for 15 minutes.



Heat shock for 40 seconds in a 42oC waterbath, and incubate on ice for 2 minutes.
Add 60 μl S.O.C. medium and incubate at 3 oC for 1 hour (in shaker).



Place all of the reaction mix on an LB/Agar/IPTG/Xgal/Amp plate and incubate
plate at 37oC overnight.

Prepare colony PCR mix
20 μM M13 orward Primer

0. μl

20 μM M13 Reverse Primer

0. μl

Taq 10x PCR Buffer

3. μl

10 mM dNTP

0. μl

50 mM MgCl2

1.0 μl

Taq DNA Polymerase

0.28 μl

H2O

28.0 μl
3 μl Total

Add 3 μl Colony PCR master mix into a PCR tube.


Pick a white bacterial colony from the plate with a pipette tip, and swirl it into the
PCR reaction.



Amplify with denaturation for 10 minutes at 94oC, followed by 30 cycles of 45
seconds at 94oC, 30 seconds at 57oC, and 1 minute at 72oC; and a final 10 minute
elongation step at 72oC. Electrophorese 4 μl on a 1. % agarose gel. Send ~30 μl
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of the PCR product for sequencing. Note: For oocytes, 5 colony PCR products are
sequenced.


Once sequencing results are obtained, methylation patterns can be read. Any
original CG that remained as a CG was methylated, and any original CG that is
now a TG was unmethylated.

2.3

Representative Results
In our work, we assay imprinted methylation in individual oocytes and embryos

(Figure 2-1). Following nested PCR amplification using bisulfite converted primers, it is
possible to confirm a successful conversion by visualizing a correct fragment size on an
agarose gel (Figure 2-2). An individual oocyte represents one parental allele, and in
theory, has one imprinted methylation pattern. As such, second round PCR products can
be tested for unintentional contamination. A restriction enzyme sensitive to DNA
methylation (such as HinfI or DpnII) can be used to digest the second round PCR product
to assess whether it contains a methylated or unmethylated allele (Figure 2-3). A
methylated C within the enzyme recognition sequence is cleaved while an unmethylated
C that is converted to T is no longer recognized by the enzyme and is uncut. Any MII
oocyte sample containing both methylated and unmethylated alleles should be discarded,
as it is indicative of cumulus cell contamination. While it may instead be inclusion of a
polar body having a dissimilar methylation pattern at the cut site, cumulus cell
contamination cannot be ruled out at this point. (Figure 2-3). Following ligation and
transformation, successful colony PCR amplification can be visualized on an agarose gel
to ensure samples with the correct product size are sent for sequencing (Figure 2-4).
Finally, the sequence of five individual clones from an MII oocyte should produce five
identical methylation patterns (Figure 2-5a). Any samples that contain more than one
pattern should be discarded (Figure 2-5b). Since ovulated MII oocytes have two
chromosome copies or an attached polar body, there is a possibility for obtaining two
similar sequence patterns (Figure 2-5c). We recommend discarding data from oocytes
that have highly dissimilar methylation patterns since cumulus cell contamination cannot
be ruled out.
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Figure 2- 1 Schematic of the Single Oocyte Bisulfite Mutagenesis Assay
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Figure 2- 2 Representative results from the 2nd round amplification of Snrpn from a
single MII oocyte on a 1.5% agarose gel
Lanes 1-4 are four single MII oocytes and lane 5 is a negative control (no oocyte).
Expected amplicon size for Snrpn is 420 bp. L, ladder.
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Figure 2- 3 Representative results
from the 2nd round methylationspecific restriction digestion for Snrpn
from a single MII oocyte on an 8%
acrylamide gel
HinfI
digestion

diagnostic

shows

restriction

unmethylated

DNA

which harbors a T that abolishes the
restriction

site

(420bp,

lane

1)

or

methylated DNA which contains a C
within recognition site (cut, 262, 103, and
54 bp, lane 2). Digestion showing both
methylated and unmethylated restriction
enzyme sites (cut & uncut bands, lane 3)
are

indicative

of

contamination. L, ladder.

cumulus

cell
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Figure 2- 4 Representative results for colony PCR amplification for Snrpn from a
single MII oocyte on a 1.5% agarose gel
Expected amplicon size following ligation of Snrpn into the pGEM-T Easy vector
and using M13 forward and reverse primers is 656 bp. Lane 1-8, amplicons from clones
1-8. Clone 5 has an incorrect amplicon size and should not be sent for sequencing.
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Figure 2- 5 Representative sequencing results for Snrpn from a single MII oocyte
Snrpn is methylated in oocytes. Black circles indicate methylated CpGs. White
circles indicate unmethylated CpGs. CpG number and placement is representative for a
B6 strain female mouse. a) Expected sequencing results for Snrpn from a single MII
oocyte. Only a single strand of DNA should amplify in all five clones. Oocytes with a
single methylation pattern and identical non-CpG conversion pattern (percentage
indicated to the right, based on number of non-CpG cytosines converted to thymine as a
percentage of total non-CpG cytosines) should be included in analyses. b) Sequencing
results for Snrpn from a single MII oocyte with cumulus cell contamination. Note the
dissimilarity between methylation states and conversion patterns indicating multiple
strand amplification. c) Sequencing results for Snrpn from a single MII oocyte with both
chromosome copies or polar body inclusion.
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2.4

Discussion
This single oocyte assay contains many steps with a number that are critical and

require special care. The first is oocyte washing. It is particularly important to wash each
oocyte multiple times in fresh medium drops following hyaluronidase treatment to
remove as many cumulus cells as possible. Moreover, when transferring oocytes to acidic
tyrode’s solution for zona pellucida removal make sure surrounding medium is clear of
cumulus cells. The oocyte is very sticky following zona removal, and any surrounding
cumulus cells can easily become stuck to the oocyte. It is very difficult to remove a
cumulus cell that is stuck to a zona-free oocyte. While this protocol allows for detection
of cumulus cell contamination at later time points, it is not constructive, nor economical,
to undergo the full protocol on oocytes that will likely be discarded.
The second critical step is oocyte embedding. When embedding the oocyte in the
agarose and lysis solution, it is important to note that low melting point (LMP) agarose
will harden at temperatures as little as 5oC below 70oC. As such, we recommend mixing
the agarose and lysis solution at 70oC, and then placing the individual oocyte on the glass
slide in minimal medium. Once ready, pipette the agarose/lysis solution and embed the
oocyte into a prepared eppendorf tube under mineral oil, in a careful yet timely manner.
It is critical that heat inactivation of the proteinase K be performed at 90 oC for 2.5
minutes. Deviation from this is not recommended. Higher temperatures or longer times
may damage the DNA, while lower temperatures or shorter times may not inactivate the
proteinase K.
As a reminder, sodium bisulfite and hydroquinone are light sensitive. Solutions
should be prepared and then wrapped in foil, amber tubes and/or placed in a dark drawer
until use. Once the bisulfite solution has been added to the tube, the tube should be
covered with foil or a dark covered bag when incubating at 50oC. We use empty foil bags
from GE Healthcare that originally contained the hot start PCR beads.
Finally, as with most PCRs, we recommend preparing each round in a timely
manner. Excessive delays, particularly after mixing at 70oC, will reduce success rate of
amplification.
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At the current time, one limitation of the protocol is that the success rate of
bisulfite converted DNA amplification from individual oocytes ranges from 40% to 65%
depending on the gene fragment amplified. While additional trouble-shooting may
increase this percentage, there is a trade-off between the bisulfite conversion treatment
being too long or harsh and not having sufficient conversion rates (>85-90%). A second
limitation is that, currently bisulfite mutagenesis cannot distinguish between 5methylcytosine

(5mC)

and

5-hydroxymethylcytosine

(5hmC).

While

5mC

is

predominantly a repressive mark and is used to signify silenced alleles, 5hmC is a
possible intermediate in the demethylation pathway (Tahiliani et al. 2009) and thus,
results at this time cannot differentiate between these two potentially opposing functions.
Several modifications may be required based on gene or region of interest. The
bisulfite conversion time may require optimization for the highest conversion percentage
with the lowest DNA damage. We suggest a range of 2.5 to 4 hours (half hour
increments) for bisulfite treatment. Further optimization can involve PCR primer design
for converted sequences of interest (for example http://www.urogene.org/methprimer/),
as well as optimization of PCR programs based on fragment length and CG content (see
Patterson et al for additional bisulfite mutagenesis optimization options (Patterson et al.
2011)). A final modification is that gel extraction of the 2nd round PCR product may be
required if there is abundant primer-dimers or non-specific amplicons that will integrate
into the vector when cloned.
We have previously shown that this protocol is effective for individual MII
oocytes (Denomme et al. 2011). We have also tested its efficiency on growing oocytes at
a range of different oocyte diameters, with the same rates of successful amplification of
converted DNA. Future applications may include analysis of DNA methylation patterns
in single cells of any origin, including in vivo-derived and cultured cells. Additionally,
we have developed an individual blastocyst assay that recovers DNA and RNA from the
same embryo, allowing for both expression and methylation data to be obtained.
However, the blastocyst is the latest stage in preimplantation development, and this assay
was not feasible for methylation studies on smaller cell numbers. Analysis of individual
oocytes and early embryos is essential for reproductive and developmental biology
studies, specifically in relation to assisted reproduction and other techniques that involve
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manipulations of germ cells and early embryos. A future application will involve
modifying the single oocyte assay to recover RNA for expression analyses as well as
DNA for methylation assays. To note, this assay has a possibility of undetected cumulus
cell contamination when the cumulus cell has the same expected methylation pattern as
the oocyte. A future modification would include optimization of duplex assays within the
same oocyte, similar to the method described by El Hajj et al (El Hajj et al. 2011), which
would allow for methylation detection at a second gene with opposing expected
methylation pattern as the gene of interest.
DNA methylation analyses can range from genome-wide to locus-specific.
Genome-wide methods such as methylated DNA immunoprecipitation (MeDIP) in
conjunction with microarrays or sequencing typically require abundant amounts of
material. Locus-specific methods that include combined bisulfite restriction analysis
(COBRA) using methylation-specific restriction enzymes, or the MethylDetector kit
(Active Motif), are less than optimal for single blastocyst analyses, resulting in
insufficient recovery of DNA, PCR bias and lack of reproducibility. Recently, Hajj et al
utilized the EZ-DNA Methylation kit (Zymo Research) along with a limited dilution
bisulfite pyrosequencing technique (El Hajj et al. 2011). The authors used this method to
analyze methylation at four loci within individual 2-cell mouse embryos, however their
allele recovery percentage was low (13-25%). When analyzing bovine oocytes, again the
authors recovered only 34% of oocyte DNA (and 8% polar body DNA). These low
percentages may be due in part to the use of columns and elution buffers, as kits are
known to reduce DNA recovery. Diluting and then transferring samples following
bisulfite mutagenesis would also likely result in some loss of the minute amount of DNA.
Bisulfite mutagenesis is the gold standard for analyzing DNA methylation, and it
is clear that the analysis of single cells is of great advantage. Agarose embedding permits
smaller sample sizes to be analyzed with bisulfite treatment without the use of kits, as
agarose protects against DNA degradation and prevents DNA loss during numerous
protocol steps. However, when compared to the blastocyst, a single oocyte has
approximately 3-6 pg of genomic DNA. Meng et al utilized LMP agarose to embed the
oocyte prior to bisulfite mutagenesis (Meng et al. 2008). Our modified protocol, which
embeds single oocytes in agarose containing lysis buffer, prevents DNA loss beginning at

63
the initial lysis step and moderates the harsh bisulfite treatment. In summary, the
advantage of single oocyte analysis is that it allows detection of inadvertent cumulus cell
contamination as well unmasking rare events and eliminating any biases undetected in
pooled samples. Altogether, this modified protocol provides quality data on the
methylation state of individual oocytes and early embryos.
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3

CHAPTER 3: The Effects of Maternal Infertility and
Subfertility on Imprint Acquisition

The work in this chapter originates from the following peer-reviewed article:
Denomme MM, White CR, Gillio-Meina C, Macdonald WA, Deroo BJ, Kidder GM &
Mann MR (2012) Compromised fertility disrupts Peg1 but not Snrpn and Peg3 imprinted
methylation acquisition in mouse oocytes. Front Genet 3 129

3.1

Introduction
The tight regulation of monoallelic gene expression based on gametic origin is

termed genomic imprinting (Bartolomei & Ferguson-Smith 2011). This dynamic process
relies on epigenetic modifications such as DNA methylation to mark, or “imprint”, one of
the two parental alleles, resulting in differential gene expression in progeny (Verona et al.
2003). Gametogenesis encompasses the critical period of heritable epigenetic
reprogramming for imprinted genes. Imprinted DNA methylation is first erased in
primordial germ cells, subsequently allowing for de novo differential methylation at
imprinted loci in oocytes and sperm (Li & Sasaki 2011). In males, de novo DNA
methylation acquisition occurs during the prenatal stages of spermatogenesis, beginning
in prospermatogonia and is completed by birth (Kafri et al. 1992, Davis et al. 1999,
Davis et al. 2000, Ueda et al. 2000). In females, de novo DNA methylation is acquired
after oocytes enter the growth phase of follicular development, from the primary to antral
follicle stage (Lucifero et al. 2004, Hiura et al. 2006, Sato et al. 2007, Song et al. 2009).
Importantly for oocytes, imprinted methylation acquisition is dependent on oocyte size
and not oocyte age, with methylation levels increasing as oocyte diameter increases.
The correct establishment of germline imprints is significant as disruptions to this
process can result in the development of imprinting disorders such as BeckwithWiedemann Syndrome (BWS), Silver-Russell Syndrome (SRS), and Angelman
Syndrome (AS). BWS is an overgrowth disorder that is caused by imprinting defects that

67
result in a gain of maternal methylation at the H19 imprinting control region (ICR) or a
loss of maternal-specific methylation at the KCNQ1OT1 (KCNQ1 overlapping transcript
1) ICR (Weksberg et al. 2010). SRS is an intrauterine growth restricted imprinting
disorder with imprinting defects at the H19 and possibly at the paternally-expressed gene
1 (PEG1) imprinted domains (Eggermann 2010). AS is a neurological disorder that is
caused by loss of maternal-specific methylation at the small nuclear ribonucleoprotein N
(SNRPN) ICR (Mabb et al. 2011). Sporadic epigenetic errors resulting in these disorders
are reported to occur more frequently in the assisted reproductive technologies (ARTs)
population (Cox et al. 2002, DeBaun et al. 2003, Gicquel et al. 2003, Maher et al. 2003,
Orstavik et al. 2003, Halliday et al. 2004, Chang et al. 2005, Ludwig et al. 2005,
Rossignol et al. 2006, Azzi et al. 2009, Bliek et al. 2009, Lim et al. 2009, Lennerz et al.
2010, Turner et al. 2010). For AS, patients at the highest risk for an imprinting defect
have parents with prolonged infertility undergoing infertility treatment (Ludwig et al.
2005, Doornbos et al. 2007). This raises the question as to whether imprinting errors in
ART patients are associated with parental infertility/subfertility. While studies have been
conducted to determine the effects of ARTs on genomic imprinting, investigations of
how impaired infertility may contribute to imprinting errors are lacking. In this study, we
queried whether impaired fertility arising during oogenesis could lead to imprinting
defects.
Development of healthy oocytes is dependent on interactions between the
growing oocyte and surrounding follicular cells (Kidder & Vanderhyden 2010). Oocytes
play an important role in regulating granulosa cell development, proliferation, and
differentiation, as well as steroid hormone production. In turn, follicular cells play a
critical role in oocyte growth, meiotic progression, and transcriptional activity and
chromatin remodeling of the oocyte genome. This synergistic partnership is facilitated by
endocrine and paracrine signaling, and intercellular gap junctional communication,
ensuring meiotic and developmental competence of the oocyte. In this study, we
specifically examined the effects of aberrant signaling and communication on imprint
acquisition.
A complex endocrine signaling pathway is active in the ovary that regulates
follicle and oocyte development. 1 β-estradiol acting through nuclear estrogen receptor
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beta (ERβ) augments the actions of follicle stimulating hormone (FSH). In the ovary,
ERβ is expressed primarily in granulosa cells and at low levels in the oocyte (Drummond
& Fuller 2011). Female mice bearing a targeted deletion of the ERβ (Esr2) gene are
subfertile, producing fewer oocytes following superovulation, as well as litters with fewer
pups (Krege et al. 1998, Couse et al. 2000, Dupont et al. 2000, Couse et al. 2003, Couse
et al. 2005, Emmen et al. 2005). Attenuated differentiation of granulosa cells following
gonadotropin stimulation in Esr2-null mice leads to decreased antrum formation, delayed
follicle maturation, and reduced follicular rupture, producing greater numbers of atretic
follicles and fewer preovulatory oocytes. In addition, vascularization of the thecal layer,
which is required for follicular growth, is impaired (Inzunza et al. 2007).
Mechanistically, ERβ is required for optimal cAMP production in mouse granulosa cells
following gonadotropin stimulation (Deroo et al. 2009). ERβ deficiency causes
disruption of cAMP second messenger signaling in granulosa cells in response to FSH,
producing aberrant FSH-regulated gene expression, decreased response to luteinizing
hormone, and impaired ovulation and fertility.
Gap junctions are specialized channels composed of six membrane proteins
termed connexins (CX). These channels are essential for communication between
neighbouring cells (Harris 2001). In the mouse, CX37 and CX43 are the only connexins
known to be required in developing follicles (Kidder & Vanderhyden 2010). CX43
localizes to gap junctions in the granulosa cell membranes, enabling granulosa cell to
granulosa cell communication. By comparison, CX37 constitutes the gap junctions
coupling the oocyte with surrounding granulosa cells and is specifically located at the
interface between the oocyte and the first layer of granulosa cells (Simon et al. 1997).
Gap junctions allow the transport of nutrients, metabolites and second messengers, such
as cAMP, between the granulosa cells and the oocyte (Kidder & Vanderhyden 2010).
Targeted deletion of the CX37 (Gja4) gene causes arrested folliculogenesis at the early
antral stage, impaired oocyte development and meiotic competency, and premature
luteinization of the follicles (Simon et al. 1997, Carabatsos et al. 2000).
In this study, we employed the Esr2-/- and Gja4-/- genetic models to interfere
specifically with endocrine signaling and gap junctional communication, compromising
fertility. We hypothesized that inhibition of the ERβ pathway and/or oocyte-granulosa
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cell gap junctional communication would lead to perturbations in imprinted methylation
acquisition. To compare mutant oocytes to control oocytes, DNA methylation acquisition
was first examined in individual, 20-80 μm control oocytes at three imprinted genes,
Snrpn, Peg3 and Peg1 (also known as Mest). Similar to previous studies (Lucifero et al.
2004, Hiura et al. 2006, Sato et al. 2007, Song et al. 2009), we observed that each gene
had its own size-dependent acquisition kinetics. To determine whether compromised
endocrine signaling and gap junctional communication disrupted de novo methylation
acquisition, preovulatory oocytes from Esr2-/- females, and early antral stage oocytes
from Gja4-/- mice were assessed for DNA methylation establishment at Snrpn, Peg3 and
Peg1. We observed no aberrant or delayed acquisition of DNA methylation at Snrpn,
Peg3 and Peg1 in preovulatory oocytes from ERβ deficient females. Similarly, we found
no perturbation of Snrpn and Peg3 de novo methylation in oocytes from CX37-null
follicles. However, Peg1 methylation acquisition was lost or delayed in Gja4-deficient
oocytes compared to controls. We attribute this to the late establishment of DNA
methylation at the Peg1 gene. These results indicate that compromised fertility though
impaired intercellular communication can lead to imprinting acquisition errors. Further
studies are required to determine the postfertilization effects of subfertility/infertility
originating from impaired signaling and intercellular communication during oogenesis.
3.2

Material and Methods

3.2.1 Oocyte Isolation
3.2.1.1 Control Oocyte Collections
Ovaries were obtained from C57BL/6 female mice (Charles River) at 10, 14, 21
and 28 days post partum (dpp), and placed in Waymouth MB 752/1 medium (Invitrogen)
supplemented with 10% fetal bovine serum (Li et al. 2007).

For further follicle

separation, ovaries were digested in the same medium containing 2 mg/mL type I
collagenase (Sigma-Aldrich) at 37°C. Primary, secondary and early tertiary (antral)
follicles were liberated by repeated aspiration and expulsion with a 1 mL pipette.
Follicles were washed several times in culture medium without collagenase. For oocyte
isolation, follicles were centrifuged for 5 minutes at 4,000 rpm, re-suspended and
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digested in 0.05% Trypsin/EDTA in a culture dish for 15 minutes at 37°C. Oocytes were
dissociated from the granulosa cells by repeated aspiration and expulsion with a 1 mL
pipette. Oocytes were retrieved through mouth pipetting and placed in 30 μL drops of M2
medium (Sigma) for further analysis.
3.2.1.2 Gja4-null Oocyte Collections
Ovaries were removed from Gja4-/- female mice (C57BL/6 background) at 21 and
28 dpp, and placed in Waymouth MB 752/1 medium (Invitrogen) supplemented with
10% fetal bovine serum. Gja4-null oocytes were retrieved through the same collection
method as control oocytes and placed in 30 μL M2 medium (Sigma) for further analysis.
3.2.1.3 Esr2-null Oocyte Collections
Ovaries were removed from Esr2-/- females (C57BL/6 background) at 28 dpp and
placed in a 100-mm cell culture dish containing 15 mL ice-cold M199 medium (Sigma)
supplemented with 1 mg/mL BSA (Invitrogen) and 2.5 g/mL gentamicin (Invitrogen)
(Deroo et al. 2009). Follicles were released by manual puncture with 25-gauge needles
and subsequent pressure applied with a sterile spatula. Oocytes were retrieved through
mouth pipetting and transferred to 30 μL drops of M2 medium (Sigma) for further
analysis.
3.2.2 Single Oocyte Bisulfite Mutagenesis and Sequencing
Processing, embedding and bisulfite mutagenesis of individual oocytes was
performed as previously described (Denomme et al. 2011). Briefly, oocytes were treated
with 0.3 mg/mL hyaluronidase (Sigma) to remove any surrounding cumulus cells (if
present), washed three times in 30 μL drops of M2 medium (Sigma), and then imaged
using the Olympus IX81 microscope. Oocyte diameter was measured using
Macnification v.1.8 (Orbicule).

ollowing treatment with acidic Tyrode’s solution

(Sigma) to remove the zona pellucida (if present), oocytes were washed twice in M2
medium, then individual oocytes were embedded in 10 μL of 2:1 LMP agarose and lysis
solution [100 mM Tris–HCl, pH 7.5 (Bioshop), 500 mM LiCl (Sigma), 10 mM EDTA,
pH 8.0 (Sigma), 1% LiDS (Bioshop), and mM DTT (Sigma)], 1 μL 2 mg/mL proteinase
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[Sigma], and 1 μL 10% Igepal [Sigma]] under 300 μL of mineral oil (Sigma), and
placed on ice for 10 min for the agarose to harden. Mineral oil was replaced with 00 μL
SDS lysis buffer [4 0 μL 1X Tris EDTA (TE), pH . (10mM Tris (Bioshop), 1mM
EDTA), 0 μL 10% SDS (Bioshop), 1 μL 2 mg/mL proteinase

] and incubated at 0°C

overnight. ollowing overnight incubation, lysis buffer was replaced with 300 μL mineral
oil and oocytes were either immediately treated for bisulfite conversion or frozen at
-20°C for up to five days. Firstly, samples were placed at 90°C for 2.5 min to heat
inactivate the proteinase K, and then DNA was denatured using 0.1 M NaOH (Sigma) at
37°C for 15 min. Treatment with 2.5 M bisulfite solution (0.125 M hydroquinone
[Sigma], 3.8 g sodium hydrogen sulfite [Sigma], 5.5 mL water, and 1 mL 3 M NaOH) at
50°C for 3.5 hours was followed by desulfonation using 0.3 M NaOH at 37°C for 15 min.
Samples were washed twice in 1X TE pH 7.5 and twice in water, and then added directly
to a Ready-To-Go PCR bead (GE) consisting of 1 μL water, gene-specific primers and 1
μL of 240 ng/mL transfer RNA as a carrier, with 2 μL mineral oil overlay. Negative
controls (no oocyte) were processed alongside each bisulfite reaction. PCR amplification
of the Snrpn ICR, Peg3 DMR and Peg1 DMR was performed as previously described
(Market-Velker et al. 2010b). Following ligation into the PGEM-T easy vector
(Promega) and cloning, 30 μL of colony PCR product was sent to Bio-Basic Inc.
(Markham, Ontario, Canada) for sequencing. For each sample, five clones were
sequenced. As MI oocytes have not extruded the first polar body, both alleles were
successfully amplified in some oocytes, and only one allele was detectable in other
oocytes. Oocytes with more than two clones having very different methylation patterns
and different non-CpG conversion rates were excluded from analysis, as cumulus cell
contamination could not be ruled out. Table 3-1 gives the number of oocytes included
and excluded from analysis per gene.
3.2.3 Statistical Analysis
For each imprinted gene, significant difference of CpG methylation percentage
was determined by a two-tailed Mann-Whitney test between mutant oocytes and control
oocytes matched for size.
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Table 3- 1 Number of Oocytes Included and Excluded from Analysis

IN, included oocytes with one to two clone patterns; EX, excluded oocytes
with 3 or more clone patterns.
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A diameter range of 6 to 80 μm was used to compare Esr2-deficient oocytes to
control oocytes, while the 3 to 60 μm diameter range (including O468 for Snrpn with a
diameter of 60. μm) was used to compare the Gja4-deficient to control oocytes. A Pvalue less than 0.05 was taken to be statistically significant.
3.3

Results

3.3.1 Methylation Acquisition in Control Oocytes correlates with Oocyte Diameter
In female mammals, imprinted DNA methylation has been shown to arise during
follicle growth from the primary to the antral stage in correlation with oocyte diameter
(Lucifero et al. 2004, Hiura et al. 2006), with gene-specific kinetics for imprint
acquisition. However, these analyses were performed with pooled oocytes of different
sizes. To compare individual mutant oocytes to control oocytes, we first needed to
examine imprinted DNA methylation acquisition in individual control oocytes. C57BL/6
oocytes were collected at 10, 14, 21 and 28 dpp to obtain oocytes with a diameter range
of 20 to 80 μm. Oocytes that were collected at 10 dpp displayed a diameter range of 20 to
0 μm, those at 14 dpp were 40 to 80 μm in diameter, at 21 dpp ranged from 0 to 0 μm,
and at 28 dpp ranged from 60 to 80 μm in diameter.
Analysis of de novo methylation acquisition at the Snrpn ICR showed mean
methylation levels of 8.7% in 20-40 μm, 12.6% in 40-4 μm, 3. % in 4 - 0 μm, 3 % in
50-

μm, 82. % in

μm, and 100.0% in

-60 μm, 9 .0% in 60-6 μm, 86.2% in 6 - 0 μm, 93.8% in 0-75
-80 μm oocytes (Figure 3-1 and 3-2). Likewise, mean methylation

levels at the Peg3 DMR were 1.6% in 20-40 μm, 11.2% in 40-4 μm, 16.1% in 4 -50
μm, 22.9% in 090% in 70-

μm, 1. % in

μm, and 9 .8% in

-60 μm, 8.1% in 60-6 μm, 81.0% in 6 - 0 μm,
-80 μm oocytes (Figure 3-3 and 3-4). For the Peg1

DMR, mean methylation levels were 4.9% in 20-40 μm, 6.8% in 40-4 μm, 12. % in 4 0 μm, 1 .9% in 0100.0% in 70-

μm, 4 . % in

μm, and 9 .0% in

-60 μm, 1.6% in 60-6 μm, 93.3% in 6 - 0 μm,
-80 μm oocytes (Figure 3-5 and 3-6). Thus, we

observed that each gene had its own acquisition kinetics. DNA methylation acquisition
began first for Snrpn at ~ 0 μm and was near completion at >

μm.
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Figure 3- 1 Methylation Analysis of the Snrpn
ICR in Control C57BL/6 Oocytes
The Snrpn ICR region analyzed contains
16 CpGs. Black circles indicate methylated
CpGs while white circles indicate unmethylated
CpGs. Each row represents an individual oocyte
(designation indicated to the left). Methylation
percentage and diameter for each oocyte is
shown at the right. Oocytes are grouped into
cohorts ranging from 20 μm to 80 μm diameters
in

μm increments. Oocytes with one

methylation pattern represent one of the two
parental alleles detected. Oocytes with two
methylation patterns represent detection of both
parental alleles.
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Figure 3- 2 Methylation Percentage at the Snrpn ICR in Relation to Oocyte Diameter
For oocytes with two parental alleles, each allele was graphed separately. Blue
diamonds represent oocytes from control females, red circles represent oocytes from
Esr2-/- females, and green triangles represent oocytes from Gja4-/- females.
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Figure 3- 3 Methylation Analysis of the
Peg3 DMR in Control C57BL/6 Oocytes

The Peg3 DMR region analyzed
contains 23 CpGs. Details are described in
Figure 3-1.
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Figure 3- 4 Methylation Percentage at the Peg3 ICR in Relation to Oocyte Diameter
Oocytes from control females, Esr2-/- females and Gja4-/- females are represented
by blue diamonds, red circles and green triangles, respectively.
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Figure 3- 5 Methylation Analysis of the
Peg1 DMR in Control C57BL/6 Oocytes
The Peg1 DMR region analyzed
contains 15 CpGs. Details are described
in Figure 3-1.
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Figure 3- 6 Methylation Percentage at the Peg1 DMR in Relation to Oocyte Diameter
Oocytes from control females, Esr2-/- females and Gja4-/- females are represented
by blue diamonds, red circles and green triangles, respectively.
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Next was Peg3, where DNA methylation acquisition was initiated at ~45 μm and
nearly complete at >6 μm, which was followed by Peg1, where DNA methylation
acquisition began at ~

μm and was near completion by > 0 μm. Snrpn had the shortest

acquisition interval while Peg3 had the longest.
3.3.2 Methylation Acquisition in ERβ-deficient Oocytes
Ovaries deficient in Esr2 produce a reduced number of maturing oocytes, but
those that do mature appear to not be developmentally compromised (Krege et al. 1998).
Consistent with this, we recovered a small number of oocytes from 28 dpp females,
ranging in diameter size from 61μm to 82 μm, corresponding to the preovulatory stage in
oocyte growth. To investigate the role of reduced hormone signaling on imprint
acquisition, we analyzed the progression of DNA methylation acquisition in developing
oocytes from mice deficient in Esr2. For the Snrpn ICR, mean methylation levels were
72.8% for 65- 0 μm, 98.8% for 0-

μm, and 100.0% for

-80 μm oocytes (Figure 3-2

and 3-7). For the Peg3 DMR, mean methylation was 100.0% in 65- 0 μm, 99.4% in 0μm, and 98. % in

-80 μm oocytes (Figure 3-4 and 3-8). For the Peg1 DMR, mean

methylation levels were 96.5% for 65- 0 μm, 9 .1% for 0-

μm, and 96. % for

-80

μm oocytes (Figure 3-6 and 3-9). Thus, oocytes from Esr2-null females had comparable
DNA methylation levels to control oocytes, indicating that imprint DNA methylation
acquisition was unaffected by Esr2 deficiency.
3.3.3 Methylation Acquisition in CX37-deficient Oocytes
Previous analyses have shown that oocytes in CX37 null ovaries arrest
development before reaching meiotic competence, around the time the antrum begins to
form (~21 dpp) (Simon et al. 1997, Carabatsos et al. 2000, Li et al. 2007). We collected
and analyzed oocytes from Gja4–null 21 dpp females, which ranged in diameter sizes
from 3 to

μm and from 28 dpp females, which ranged in size from 0 to 60. μm.

The maximum diameter obtained was 60. μm, consistent with previous studies (Simon
et al. 1997, Carabatsos et al. 2000). To explore the relationship between gap junction loss
and imprint acquisition, we analyzed the progression of DNA methylation establishment
in developing oocytes from Gja4-deficient mice.
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Figure 3- 7 Methylation Analysis of the Snrpn ICR in Esr2-null Oocytes
Details are described in Figure 3-1.
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Figure 3- 8 Methylation Analysis of the Peg3 DMR in Esr2-null Oocytes
Details are described in Figure 3-1.
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Figure 3- 9 Methylation Analysis of the Peg1 DMR in Esr2-null Oocytes
Details are described in Figure 3-1.
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Figure 3- 10 Methylation Analysis
of the Snrpn ICR in Gja4-null
Oocytes
Details
Figure 3-1.

are

described

in
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Figure 3- 11 Methylation Analysis
of the Peg3 DMR in Gja4-null
Oocytes
Details are described in Figure 3-1.
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Figure 3- 12 Methylation Analysis
of the Peg1 DMR in Gja4-null
Oocytes

Details
Figure 3-1.

are

described

in
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At the Snrpn ICR, mean methylation levels were 6.3% in 35-40 μm, 14.0% in 404 μm, 1 .4% in 4 - 0 μm, 4 .8% in 0-

μm, 80.8% in

-60 μm, and 88.0% in 60-65

μm oocytes (Figure 3-2 and 3-10). No significant difference was observed in
methylation levels between Gja4-null and control oocytes.
Analysis at the Peg3 DMR showed mean methylation levels of 2.7% for 35-40
μm, 4.0% in 40-4 μm, 28.0% for 4 - 0 μm, 0. % for 0-

μm, and

.3% for

-60

μm oocytes (Figure 3-4 and 3-11). No significant difference was observed in
methylation levels between Gja4-null and control oocytes. For the Peg1 DMR, mean
methylation levels were 1.8% in 35-40 μm, 1.4% in 40-4 μm, 9. % in 4 - 0 μm, 14.3%
in 50-

μm, and 19.1% in

-60 μm oocytes (Figure 3-6 and 3-12). Statistical analysis

of Peg1 showed a significant difference in methylation acquisition between control and
Gja4-deficient oocytes (P = 0.0006). Because Gja4-null oocytes stop growing and are
eventually lost from the follicles, it could not be determined whether this is a delay or a
disruption in Peg1 DNA methylation acquisition.
3.4

Discussion
Growth and maturation of oocytes within follicles requires bidirectional signaling

and exchange of nutrients, metabolites and second messengers through gap junctions
between the oocyte and granulosa cells (Matzuk et al. 2002, Gilchrist et al. 2008, Su et
al. 2009). Aberrant endocrine signaling and loss of gap junctional communication
between the oocyte and granulosa cells leads to compromised folliculogenesis, oocyte
maturation and oocyte competency, consequently impairing fertility. Given that oocytespecific DNA methylation establishment at imprinted genes occurs during this growth
phase, we determined whether compromised endocrine signaling and gap junctional
communication would disrupt de novo methylation acquisition. Individual oocytes from
Esr2- and Gja4-deficient mice were assessed for DNA methylation establishment at
Snrpn, Peg3 and Peg1. We observed no aberrant or delayed acquisition of DNA
methylation at Snrpn, Peg3 or Peg1 in oocytes from Esr2-deficient females, and no
perturbation in Snrpn or Peg3 de novo methylation in oocytes from Gja4-null females.
However, Gja4-deficiency resulted in a loss or delay in methylation acquisition at Peg1.
One possible explanation for this difference between the three loci analyzed is the late
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establishment of DNA methylation at the Peg1 gene. These results indicate that
compromised fertility though impaired intercellular communication can lead to
imprinting acquisition errors. Further studies are required to determine whether
subfertility/infertility

originating

from

impaired

signaling

and

intercellular

communication during oogenesis has an effect postfertilization on imprint maintenance in
the preimplantation embryo.
3.4.1 Gene-specific Methylation Acquisition according to Oocyte Size
This study is the first to investigate imprint methylation acquisition of Snrpn,
Peg3, and Peg1 in individual oocytes. We observed that each gene has its own sizedependent acquisition kinetics. Snrpn had the shortest acquisition interval with de novo
methylation beginning at ~ 0 μm and near completion at >

μm. Peg3 had the earliest

and longest acquisition interval. DNA methylation acquisition was initiated at ~4 μm
and was nearly complete at >6
methylation, beginning at ~

μm. Peg1 had the latest acquisition of de novo

μm and near completion by > 0 μm. Previous studies

reported similar findings using pooled oocytes where methylation level increased with
days postpartum, follicular stage or with oocyte diameter/size, and initiation of
acquisition was gene-specific (Lucifero et al. 2004, Hiura et al. 2006, Sato et al. 2007,
Song et al. 2009). Oocyte-specific de novo methylation was also found to occur
differentially with the maternal allele acquiring methylation prior to the paternal allele for
Snrpn, Zac1 and Peg1 (Lucifero et al. 2004, Hiura et al. 2006). Our data are consistent
with this observation. Firstly, in oocytes for which two alleles were successfully
amplified, one allele possessed higher and the other allele lower methylation levels,
indicative of maternal and paternal contribution, respectively. For example, Snrpn
WT563 oocyte had 81% and 50% methylation (Figure 3-1). Secondly, for oocytes within
each diameter range (see Peg3 control oocytes between 60 and 6 μm; Figure 3-3), a
subset of oocytes had high methylation percentages (68, 71, 87 and 96%, indicative of the
maternal allele) while others had low methylation percentages (18, 28, 48, 52%,
indicative of the paternal allele). Finally, scatter plots show two distinct cohorts within
the same range of diameter measurements. For example, Peg1 control oocytes between
and 6 μm grouped into 0-40% methylation and 75-100% methylation (Figure 3-6).
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3.4.2 Compromised Fertility leads to Loss or Delayed Peg1 Methylation
Acquisition
While Gja4-deficient oocytes ceased development and did not achieve mature
size, analyses indicated that they were not compromised in their ability to catalyze DNA
methylation as de novo DNA methylation was initiated for the Snrpn and Peg3 imprinted
genes. The failure to initiate Peg1 methylation acquisition may simply be due to the fact
that oocytes lacking CX37 never reach the size necessary for de novo methylation to
commence at late-acquiring loci. However, control oocytes of comparable size (55-60
μm) displayed initiation of de novo Peg1 methylation. This suggests that Peg1
methylation acquisition was lost or delayed in mutant oocytes. Alternatively, CX37 null
oocytes may have reduced stores of methyl donors or other metabolites required for DNA
methylation that would normally be transported from granulosa cells to the oocyte via
gap junctions. If this is the case, then there must have been sufficient availability of
methyl donors in mutant oocytes for Snrpn and Peg3 de novo methylation, but oocytes
lacking junctional coupling with the granulosa cells may have exhausted their methyl
donors during oocyte growth, preventing de novo methylation at late-acquiring genes like
Peg1. To investigate the requirement for methyl donors during follicle development,
Anckaert and colleagues (2010) cultured preantral follicles in medium with low methyl
donors. While this led to impaired antrum development and polar body formation, it did
not impede the acquisition of DNA methylation at the Snrpn ICR and the Peg3 DMR
(Anckaert et al. 2010). However, a reduced level of DNA methylation was found at the
Peg1 DMR. This provides support for the argument that gap junctional communication
provides important metabolites for DNA methylation acquisition. To better understand
the mechanism leading to loss or delayed methylation acquisition, further studies are
required to assess the level of methyl donors, amount of S-adenosylmethionine, and
ability to carry out global and gene-specific methylation in 55–60 μm CX37-null or
CX37-depleted oocytes. Furthermore, methylation studies should be carried out using F1
females. For Peg1 CX3 oocytes between 4 and 60 μm, oocytes possessed 0–53%
methylation. DNA methylation acquisition was likely initiated on the maternal Peg1
allele in some oocytes, while other oocytes lacked methylation on both parental alleles.
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Thus, loss or delayed Peg1 methylation acquisition may preferentially lead to a failure of
the paternal allele to become methylated. Further studies are required to investigate this
potential grandpaternal effect.
Peg1 may also be more susceptible to perturbation by assisted reproductive
technologies. Loss of Peg1/PEG1 methylation was observed in mouse oocytes following
in vitro maturation (Kerjean et al. 2003), and human oocytes following ovarian
stimulation (Sato et al. 2007). Further studies are required to determine whether the
susceptibility of Peg1 to perturbation relates to its late acquisition of methylation or
whether a different epigenetic regulatory mechanism(s) operates at this gene.
Superovulation also caused imprinting errors in the mouse preimplantation embryo
(Market-Velker et al. 2010b). Although imprinted methylation acquisition was not
perturbed in mouse oocytes by exogenous hormone treatment (Anckaert et al. 2009a).
We hypothesized that superovulation disrupts maternal-effect gene products required for
imprint maintenance during embryo development. Thus, impaired fertility may not only
disrupt Peg1 methylation acquisition but may also lead to inadequate stores of maternal
products, including those from granulosa cells, that may disrupt imprint maintenance at
Peg1 as well as at Snrpn and Peg3 during preimplantation development. Extending
studies to preimplantation embryos generated from fertilized ERβ-deficient and CX37depleted oocytes will be required to determine their effects on imprint maintenance. In
addition, further studies are required to determine whether assisted reproductive
technologies, such as in vitro oocyte maturation and superovulation, lead to aberrant
endocrine and paracrine signaling as well as granulosa cell–oocyte gap junctional
communication.
It is important to understand granulosa cell-oocyte communication as
technological

advances

move

forward.

Procedures

such

as

slow-freezing

cryopreservation and ultra-fast vitrification of oocyte-enclosed follicles, which employ
cryoprotectants and very low temperatures, may permanently or temporally disrupt actinor tubulin-rich projections that extend from granulosa cells through the zona pellucida to
the oocyte (Kidder & Mhawi 2002). Slow-freezing of mouse, rhesus monkey and human
preantral follicles disrupted projections and uncoupled the oocyte and granulosa cells
(Barrett & Albertini 2010). Temporal disruption of oocyte-granulosa cell contacts was
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also observed following vitrification (Trapphoff et al. 2010). Thus, transfer of molecules
between the two compartments may be temporarily disturbed. While low levels of
imprinting errors were detected in a subset of oocyte pools following vitrification
(Trapphoff et al. 2010), further studies are required to determine whether disruption of
oocyte-granulosa coupling leads to errors in imprint acquisition and/or maintenance.
Continued studies in animal models and in humans are required to understand the
molecular mechanisms regulating genomic imprinting acquisition and maintenance as
well as how impaired fertility and assisted reproductive technologies induce epigenetic
changes and disease.
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4 CHAPTER 4: The Effects of Maternal Ovarian Stimulation
on Imprint Acquisition
The work in this chapter originates from the following peer-reviewed article:
Denomme MM, Zhang L, & Mann MR (2011) Embryonic imprinting perturbations do
not originate from superovulation-induced defects in DNA methylation acquisition. Fertil
Steril 96 734- 738 e732

4.1

Introduction
The prevalence of Assisted Reproductive Technologies (ARTs) is rapidly

increasing in developed countries as effective treatments for infertile couples. However,
the consequences of manipulating germ cells and early embryos are not fully known.
Accumulating evidence indicates that ART children are at increased risk for intrauterine
growth retardation, premature birth, low birth weight, and genomic imprinting disorders
(Doyle et al. 1992, Shiota & Yamada 2005).
Genomic imprinting is a transcriptional regulatory mechanism controlling unequal
gene expression based on parental-origin (Reik & Walter 2001, Jaenisch & Bird 2003).
While the majority of genes within the genome are biallelically expressed, imprinted
genes have restricted expression to either the maternally or paternally inherited allele.
The opposite parental copy is silenced by epigenetic mechanisms including DNA
methylation, where a methyl group is covalently linked to cytosines within CpG
dinucleotides (Verona et al. 2003). Germ cell and preimplantation embryo development
are critical periods in genomic imprinting regulation. During spermatogenesis, paternal
methylation imprints are acquired by the post-natal stage (Shamanski et al. 1999). During
oogenesis, maternal methylation imprints are acquired during maturation from primordial
to antral follicle in correlation with oocyte diameter (Lucifero et al. 2002, Lucifero et al.
2004, Hiura et al. 2006). Importantly, the timing of ARTs coincides with these critical
stages and presents an opportunity for the disruption of imprinting acquisition and
maintenance. Aberrant imprinting can lead to developmental disorders such as Beckwith-
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Wiedemann Syndrome (BWS) and Angelman Syndrome (AS) (Weksberg et al. 2005),
which are characterized by loss of maternal methylation at the Kcnq1ot1 and Snrpn
imprinting control regions (ICR), respectively (Cox et al. 2002, DeBaun et al. 2003,
Gicquel et al. 2003, Maher et al. 2003, Orstavik et al. 2003).
Superovulation, or ovarian stimulation, is an ART procedure that enables
increased oocyte production. It has become common practice to incorporate some form of
ovarian stimulation to treat infertility in humans. The use of high doses of exogenous
hormones has recently caused much debate surrounding their effects on oocyte
maturation (Van der Auwera & D'Hooghe 2001, Krisher 2004). Typically, multiple
ARTs procedures are performed together, and may have accumulating effects on the
mechanisms of imprinting regulation. However it has been shown that superovulation
alone as a fertility treatment can cause aberrant imprinting in offspring. As imprint
acquisition has been shown to occur relatively late in oogenesis (Obata et al. 1998,
Lucifero et al. 2004, Hiura et al. 2006), the establishment of these imprints may be
susceptible to exogenous hormone treatments. Evidence from mice includes delayed in
vitro preimplantation development, fetal growth retardation, and increased number of
abnormal blastocysts and number of resorptions (Ertzeid & Storeng 2001, Van der
Auwera & D'Hooghe 2001). At the molecular level, embryos derived from superovulated
females exhibit a higher occurrence of abnormal global methylation patterns, presenting
either complete loss of methylation in one or both nuclei, or complete methylation in one
or both nuclei (Shi & Haaf 2002). Likewise, for both BWS and AS human imprinting
disorders, patients have been identified having ovarian stimulation as the only form of
ARTs used (Young et al. 1998, Chang et al. 2005, Ludwig et al. 2005). This questions
the impact of superovulation on the ability of the oocyte to establish maternal imprints.
We have previously shown that superovulation alone affects genomic imprinting
in blastocyst stage embryos at four imprinted genes (Snrpn, Kcnq1ot1, Peg3, H19) in a
hormone dosage-dependent manner (Market-Velker et al. 2010b). A greater frequency of
aberrant methylation occurs at the high hormone dosage. As disruption of maternalinherited as well as paternal-inherited methylation was observed, we proposed that
superovulation had dual effects during oogenesis, firstly acting on imprint acquisition
within the oocyte, and secondly on maternal-effect gene products later required for
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imprint maintenance within the embryo (Market-Velker et al. 2010b). To distinguish
between these two effects, we compared the methylation levels in spontaneously ovulated
and superovulated oocytes. We hypothesized that superovulation increases the risk of
developing embryonic imprinting perturbations by affecting maternal imprint acquisition.
To address this, we analyzed the methylation patterns of Snrpn, Kcnq1ot1, Peg3, and
H19 following the same high and low exogenous hormone treatments, as our previous
study (Market-Velker et al. 2010b). Contrary to our hypothesis, we observed that
superovulation does not affect methylation acquisition at any examined imprinted loci
regardless of hormone treatment dosage. As such, our results indicate that superovulation
disrupts maternal-effect gene products required for imprint maintenance during embryo
development.
4.2

Materials and Methods

4.2.1 Ovarian Stimulation and Oocyte Collection
C57BL/6(CAST7p6) [B6(CAST7p6)] females were crossed with C57BL/6 (B6)
males to obtain B6(CAST7p6)XB6 F1 females, which inherited one Mus musculus
castaneus chromosome 7 and partial chromosome 6 (modified from (Mann et al. 2003))
from the mother, and one B6 chromosome set from the father. Strain-specific
polymorphisms between these mice allow identification of grandmaternal and
grandpaternal alleles within oocytes. To recover superovulated oocytes, F1 females were
injected with a single dose of equine Chorionic Gonadotropin (eCG, Intervet Canada)
followed by the same dose of human serum Chorionic Gonadotropin (hCG, Intervet
Canada) 46-48 hours later. Two hormone doses, 6.25 IU (low) and 10 IU (high) were
used to stimulate ovulation (Market-Velker et al. 2010b). Oocyte-cumulus cell complexes
were recovered from ampullae into M2 media (Sigma) the following day at noon (22
hours post-hCG). Control oocyte-cumulus cell complexes were collected at noon from
untreated females in the estrous stage of spontaneous ovulation cycles. Experiments were
performed in compliance with the guidelines set by the Canadian Council for Animal
Care, and the policies and procedures approved by the University of Western Ontario
Council on Animal Care.
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Oocytes were dissociated from surrounding cumulus cells using 0.3 mg/mL
hyaluronidase (Sigma) and were washed three times in 30 μL of M2 media. Two
diameter measurements were taken using the Olympus IX81 microscope, averaged then
halved for the radius. Oocyte volume was calculated V=4/3π∙r3. To compare oocyte
diameter and volume, ANOVA and t-test were performed. Following removal of the zona
pellucida using Acidic Tyrode’s solution (Sigma), oocytes were washed twice in 30 μL
M2 media and then placed individually in minimal media onto a glass slide. At 70ºC, the
oocyte was gently mixed with a small amount of 2:1 agarose:lysis solution [20 μL 3%
low melting point agarose (Sigma), 8 μL lysis buffer (100 mM Tris–HCl pH 7.5
(Bioshop), 500 mM LiCl (Sigma), 10 mM EDTA pH 8.0 (Sigma), 1% LiDS (Bioshop), 5
mM DTT (Sigma)), 1 μL 2mg/mL proteinase

(Sigma), 1 μL 10% Igepal (Sigma)] and

then embedded in 10 μL of the 2:1 agarose:lysis solution under 300 μL mineral oil
(Sigma), producing an agarose-embedded oocyte. Following a 10-minute incubation on
ice, the mineral oil was removed and 00 μL lysis buffer was added. Embedded oocytes
were incubated overnight in a 50ºC waterbath. The following day, embedded oocytes
were either processed immediately, or stored in 300 μL mineral oil at -20ºC for up to five
days. Superovulation and oocyte collection were performed on eight 6.25 IU treated
females and seven 10 IU treated females. For the untreated group, oocytes were collected
from fifteen spontaneously ovulating females.
4.2.2 Bisulfite Mutagenesis of Individual Oocytes
Bisulfite mutagenesis involving individual embedded oocytes was performed as
previously described with modification (Market-Velker et al. 2010b). In short, following
overnight incubation, lysis buffer was removed and the agarose beads were covered with
300 μL mineral oil, incubated for 2. minutes at 90ºC to heat inactivate the proteinase K,
then placed on ice for 10 minutes. DNA was denatured in 0.1 M NaOH (Sigma) at 37ºC
for 15 minutes with periodic shaking. Agarose beads were placed in a 2.5 M bisulfite
solution [0.125 M hydroquinone (Sigma), 3.8 g sodium hydrogensulfite (Sigma), 5.5 mL
water, 1 mL 3 M NaOH] at 50ºC for 3 (Kcnq1ot1) or 3.5 hours (remaining genes).
Following bisulfite mutagenesis, samples were desulfonated with 0.3 M NaOH at 37ºC
for 15 minutes with shaking. Agarose beads were washed twice each with TE pH 7.5 and
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water, then directly added, as a solid bead, to a Ready-to-Go PCR bead (GE) containing
gene-specific primers and 1 μL of 240 ng/mL tRNA as a carrier in a 1 μL solution with
2 μL mineral oil overlay. Negative controls (no oocyte) were processed alongside each
bisulfite reaction. From the first round product,

μL was added into the second round

PCR reaction with 2 μL mineral oil overlay. PCR amplification of Snrpn, Kcnq1ot1,
Peg3 and H19, and cloning was performed as described (Market-Velker et al. 2010b).
Approximately 30 μL of colony PCR reaction was sent to Bio-Basic Inc. (Markham, ON,
Canada) for sequencing. For each sample, 5 clones were sequenced. Since only one
strand of oocyte DNA is expected to amplify, any samples with more than one
methylation pattern were excluded from analysis, as this might be indicative of cumulus
cell contamination and/or polar body inclusion (Supplementary Figures 4-1s and 4-2s
in Appendix 1). Polymorphisms between the B6 and B6(CAST7p6) alleles allowed
distinction of grandparental identity for each sequence.
4.3

Results
To determine the effects of superovulation on imprint acquisition, we examined

the methylation status of the Snrpn ICR, the Kcnq1ot1 ICR, and the Peg3 differentially
methylated region (DMR), which acquire methylation during oogenesis as well as the
H19 ICR, which remains unmethylated in oocytes. Oocytes were obtained from females
undergoing spontaneous and induced ovulation. For the spontaneously ovulating group,
106 oocytes were subjected to bisulfite mutagenesis. Successful amplification was
observed for 45% of individual oocytes (48/106) (Table 4-1). Of these, 83% showed one
methylation pattern (40/48) for the imprinted gene of interest. The remaining eight
oocytes had more than one methylation pattern and were excluded from further analysis
under the assumption of cumulus cell contamination. Ten oocytes were examined for
each of the four genes. We found that the Snrpn ICR, the Kcnq1ot1 ICR and the Peg3
DMR were fully methylated in individual oocytes (Figure 4-1), similar to a previous
study (Lucifero et al. 2004). Likewise, the H19 ICR was unmethylated in individual
oocytes.
For the induced ovulation group, we examined 301 individual oocytes. Successful
amplification was observed in 48% (76/157) of the 6.25 IU treated oocytes and 56%
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(81/144) of 10 IU treated oocytes (Table 4-1). Of these, 79% (60/76) and 80% (65/81),
respectively, displayed one methylation pattern for the imprinted gene of interest. At least
fifteen oocytes for each imprinted gene were examined at each dosage.
Contrary to our hypothesis, we observed that the Snrpn ICR, the Kcnq1ot1 ICR
and the Peg3 DMR were fully methylated, while H19 was unmethylated, whether the
hormone treatment was low (Figure 4-2) or high (Figure 4-3). A single oocyte from the
10 IU hormone group showed an unmethylated Kcnq1ot1 ICR. We attribute this to a
spontaneous loss of maternal methylation, cumulus cell contamination, or a rare
imprinting error caused by ovarian stimulation. Furthermore, as both grandmaternal
(B6(CAST7p6)) and grandpaternal (B6) alleles displayed similar hypermethylation, our
results do not demonstrate differential allelic susceptibility to perturbations by
superovulation. Finally, analysis of oocyte diameter, volume, or morphology revealed no
significant difference between oocytes derived from spontaneously and induced ovulating
females (data not shown).
4.4

Discussion
In a previous study, we examined the effects of superovulation on imprinted

methylation of Snrpn, Kcnq1ot1, Peg3 and H19 in blastocyst-stage embryos recovered
from spontaneously and induced ovulating females (Market-Velker et al. 2010b). We
observed a loss of Snrpn, Kcnq1ot1 and Peg3 maternal methylation and a gain of
maternal H19 methylation. This aberrant imprinting occurred in a dose-dependent
manner, with perturbations more frequent following a high than a low hormone dosage.
As superovulation was anticipated to affect oocytes, imprinting perturbations could be
expected on the maternal, oocyte-derived allele. Surprisingly, we also observed loss of
H19 methylation on the paternal, sperm-contributed allele. This led us to propose that
superovulation had dual effects during oogenesis, disrupting imprint acquisition during
oogenesis, and producing changes in maternal-effect gene products that are later required
for imprint maintenance in resulting embryos (Market-Velker et al. 2010b).
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Table 4- 1 Single Oocyte Analysis from Spontaneous and Induced Ovulation Groups
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Figure 4- 1 Methylation Analysis in
Individual

Spontaneously

Ovulating

Oocytes
Methylation analysis at the Snrpn ICR
(A), Kcnq1ot1 ICR (B), Peg3 DMR (C), and H19
ICR (D). For each gene, n=10. Black circles
indicate methylated CpGs. White circles indicate
unmethylated CpGs. U, untreated; C, CAST
allele; B, B6 allele. Each row represents an
individual oocyte; designation indicated to the
left. The Snrpn ICR region analyzed contains 16
CpGs;

a

polymorphism

eliminates

CpG

dinucleotide 1 in the CAST allele. The Kcnq1ot1
ICR region analyzed contains 20 CpGs. The
Peg3 DMR region analyzed contains 24 CpGs; a
polymorphism eliminates CpG dinucleotide 22 in
the B6 allele. The H19 ICR region analyzed
contains 17 CpGs; a polymorphism eliminates
CpG dinucleotide 8 in the B6 allele.
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Figure

4-

2

Methylation

Analysis

in

Individual Low Dose (6.25 IU) Superovulated
Oocytes
Methylation analysis at the Snrpn ICR
(A), Kcnq1ot1 ICR (B), Peg3 DMR (C), and
H19 ICR (D). For each gene, n=15. Details are
as described in Figure 4-1.
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Figure

4-

3

Methylation

Analysis

in

Individual High Dose (10 IU) Superovulated
Oocytes
Methylation analysis at the Snrpn ICR
(A), Kcnq1ot1 ICR (B), Peg3 DMR (C), and
H19 ICR (D). For each gene, n=15-17. Details
are as described in Figure 4-1.
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To distinguish between these effects, in our current study, we analyzed
methylation acquisition in individual MII ovulated oocytes at the same imprinted genes
following the same superovulation dosage regimens. To our surprise, there were no
superovulation-induced imprinting errors. We conclude that ovarian stimulation leads to
disruption of maternal-effect gene products that are later required for imprint
maintenance during embryo development. Support for this comes from a study examining
global methylation following superovulation. They found that as early as the 2-cell stage,
embryos from superovulated females had aberrant global methylation patterns twice as
often as embryos from naturally ovulated females (Shi & Haaf 2002).
To date, investigations of the effects of superovulation on imprinting in oocytes
have been limited and have produced conflicting results. Consistent with our findings,
Anckaert et al. observed normal methylation patterns at Snrpn, Peg3 and H19 loci, along
with the Igf2r locus in pooled oocytes from superovulated female mice (Anckaert et al.
2009a). In contrast to our results, Sato et al. found an aberrant gain of DNA methylation
at the normally unmethylated H19 locus in pooled mouse oocytes, although no change in
methylation was observed for Peg1, Kcnq1ot1 and Zac. Additionally, they found that
individual human oocytes from women undergoing multiple hormone stimulations
possessed aberrant imprinting at both the PEG1 and H19 loci (Sato et al. 2007). By
analyzing individual mouse oocytes, our study obtained results from a greater number of
oocytes, and eliminated any biases based on oocyte pools and undetected cumulus cell
contamination. It is important to acknowledge that human oocytes may be more
susceptible to ovarian stimulation, although multiple ART procedures and advanced
maternal age may be confounding factors (El-Maarri et al. 2001, Borghol et al. 2006,
Geuns et al. 2007).
During oogenesis, methylation acquisition occurs in a parental-specific manner.
For Snrpn, the maternal allele is re-methylated prior to the paternal allele acquiring a
maternal methylation identity (Lucifero et al. 2004). Thus, the original grandparental
identity of the oocyte chromosomes was an important consideration in the design of this
study as the paternal allele may be more susceptible to imprint disruption, given its later
acquisition. Our results showed no difference in susceptibility to maternal imprint
acquisition between the grandparental alleles at either hormone dosage in MII oocytes.
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Analysis of early embryos will be required to determine whether there is differential
susceptibility to loss of imprint maintenance.
Our study argues against methylation acquisition as the origin for imprinting
errors following superovulation, instead supporting the notion that ovulation induction
via

exogenous

hormones

causes

aberrant

methylation

maintenance

during

preimplantation development. Acceleration of oocyte maturation by superovulation may
result in inefficacy to synthesize and store sufficient amounts of these maternal factors
(Li et al. 2010). Our findings have significant bearing on procedures involving
manipulation of oocytes, such as in vitro follicle culture and oocyte maturation, as well as
oocyte cryopreservation and vitrification. A number of studies have argued that these
methods do not increase the risks of abnormal imprinting acquisition in oocytes
(Anckaert et al. 2009a, Anckaert et al. 2009b, Trapphoff et al. 2010). However, this
study together with our previous results on the effects of superovulation on imprint
maintenance supports the importance of more in-depth investigations into the effects of
ARTs by extending studies of oocyte manipulations to the embryo.
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5 CHAPTER 5: The Effects of Maternal Ovarian Stimulation
on the Maternal-Effect Factor ZFP57

The work in this chapter originates from the following manuscript:
Denomme MM, Zhang L, Macdonald WA, White CR & Mann MR (2014)
Superovulation causes misregulation of the maternal effect factor ZFP57 involved in
genomic imprint maintenance during preimplantation, in preparation.

5.1

Introduction
Genomic imprinting is a phenomenon that leads to monoallelic expression of a

subset of genes based on parental-origin. These genes are subject to epigenetic
modifications, such as DNA methylation, that inhibit transcription of one parental allele
and others, such as active histone modifications, that permit transcription of the other
parental allele (Bartolomei & Ferguson-Smith 2011). Genomic imprinting is a twogeneration phenomenon whereby sex-specific epigenetic modifications are inherited in
the gametes of parents and these modifications are maintained in offspring to direct
monoallelic gene expression. As such, gametogenesis and preimplantation embryo
development are critical periods for imprinted DNA methylation acquisition and
maintenance, respectively. During spermatogenesis, paternal methylation imprints are
established by the post-natal stage (Saitou et al. 2012). During oogenesis, maternal
methylation imprints are acquired during maturation from primordial to antral follicle in
correlation with oocyte diameter (Lucifero et al. 2004, Hiura et al. 2006, Denomme et al.
2012). Following fertilization, differential methylation between alleles is reliably
maintained despite a global wave of genomic DNA demethylation during the
preimplantation period.
Disruption to genomic imprinting can lead to developmental disorders such as
Beckwith-Wiedemann Syndrome (BWS) and Angelman Syndrome (AS) (Weksberg et al.
2005, Horsthemke & Wagstaff 2008), which are characterized by genetic and epigenetic
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errors at the KCNQ1OT1, H19 and SNRPN imprinting control regions (ICRs),
respectively. Importantly, these syndromes have an increased prevalence in the Assisted
Reproductive Technologies (ARTs) community, suggesting a link between ARTs and
imprint dysregulation (Cox et al. 2002, DeBaun et al. 2003, Gicquel et al. 2003, Maher et
al. 2003, Orstavik et al. 2003). The timing of ARTs coincides with the critical stages of
imprint acquisition and imprint maintenance, and thus may be susceptible to disruption.
Within the last few decades, ARTs have become standard treatment of care for infertility
in developed countries. These techniques encompass manipulation of gametes and
embryos, such as ovarian stimulation (superovulation), and in vitro embryo culture.
The impact of ARTs on imprinting regulation has become the focus of intense
investigation by a number of groups. We and others have shown that DNA methylation
acquisition during oogenesis is a robust process, and interventions such as superovulation
or in vitro oocyte maturation do not perturb imprint acquisition (Anckaert et al. 2009a,
Denomme et al. 2011, Denomme & Mann 2012). However, superovulation and/or
embryo culture result in loss of imprinted DNA methylation as early as the blastocyst
stage of embryo development (Sasaki et al. 1995, Doherty et al. 2000, Mann et al. 2004,
Market-Velker et al. 2010a, Market-Velker et al. 2010b, Market Velker et al. 2012), as
well as at postimplantation time points (Mann et al. 2004, Fortier et al. 2008). Thus,
imprint maintenance is more susceptible than imprint acquisition to the adverse effects of
these techniques. This led to our hypothesis that ARTs affects a maternal-effect factor(s)
that is produced in the oocyte but is required for imprint maintenance in the embryo.
Many transcripts from the maternal genome accumulate during oocyte growth.
While the majority are used by the oocyte, some are required post-fertilization for critical
aspects of development. Since imprinting marks must be maintained through this oocyteto-embryo transition, maternal factors likely contribute to its regulation. To date, a
handful of maternal factors have been shown to play essential roles. Protection from
active zygotic demethylation occurs by binding of the maternal effect protein
developmental pluripotency-associated 3 (DPPA3/STELLA/PGC7) to H3K9me2. This
inhibits 5mC conversion to 5hmC by TET3 (Nakamura et al. 2007, Nakamura et al.
2012). Protection from passive demethylation occurs via the maternal effect proteins,
zinc finger protein 57 (ZFP57), tripartite motif 28 protein (TRIM28/KAP1), and DNA
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methyltransferase 1 (DNMT1) (Iyengar & Farnham 2011, Iyengar et al. 2011,
Messerschmidt et al. 2012). ZFP57 and TRIM28 bind to CpG methylation at imprinted
genes, attracting repressive macromolecular complexes that include DNMT1 and the
H3K9me3-catalyzing histone methyltransferase SETDB1 (Li et al. 2008, Quenneville et
al. 2011, Zuo et al. 2012). In this current study, we examined ZFP57 transcript and
protein abundance as well as ZFP57 localization in spontaneously ovulated and
superovulated oocytes and resulting embryos. We observed that superovulation leads to
increased protein levels and mislocalization away from the nucleoplasm in the early
stages of preimplantation development, and increased cytoplasmic levels remained in
subsequent preimplantation stages. This misregulation of ZFP57 preceded a decrease in
protein enrichment at imprinted domains, proposing a possible mechanism for imprint
methylation maintenance loss following ARTs.
5.2

Materials and Methods

5.2.1 Ovarian Stimulation and Oocyte Collection
Oocytes were obtained from B6(CAST7p6) (CAST chromosome 7 partial
chromosome 6 on a C57BL/6 background) female mice and embryos were obtained from
B6(CAST7p6) females and C57BL6 (B6) males to enable allelic identity.
B6(CAST7p6)xB6 F1 and B6 females were also used for immunocytochemistry and
Western blot analyses where allelic identity was not required. Female mice were injected
with a single dose of 10 IU eCG (Intervet Canada) followed by a single dose of 10 IU
hCG (Intervet Canada) 44-48 hours later. To produce embryos, females were then mated
to B6 males the same night following hCG. To obtain spontaneously ovulated embryos,
control females were checked for estrous during their natural cycle and then mated with
B6 males. Females were checked the following day for the presence of a vaginal plug.
Oocytes and 1-cell embryos were harvested from the ampulae at 0.5 days post coidum
(dpc) and dissociated from surrounding cumulus cells using 0.3 mg/mL hyaluronidase
(Sigma). Oviducts were flushed for 2-cell embryos at 1.5 dpc, 4-cell embryos at 2 dpc,
and 8-cell embryos at 2.5 dpc. Morula-stage embryos were flushed from uteri at 3 dpc
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and blastocysts at 3.5 dpc. Embryos were washed several times in 30 μL M2 media
(Sigma).
5.2.2 Gene Expression Analysis
Embryos were immediately stored at -80oC in individual 0.2 mL tubes. To
generate a cDNA library, 10 μL of Dynabead Lysis Buffer (Invitrogen) was added to preequilibrated oligo-dT Dynabeads (Invitrogen), which were then added to each 0.2 μL
tube containing an individual oocyte or embryo. RNA-oligo-dT hybridization was
conducted for 10 minutes at room temperature with shaking. On the magnetic rack, the
supernatant was removed and the samples were washed twice with Dynabead Wash
Buffer A (Invitrogen) and three times with Dynabead Wash Buffer B (Invitrogen).
Samples underwent reverse transcription, generating a cDNA library as previously
described (Market-Velker et al. 2010a, Market Velker et al. 2012). Each embryo cDNA
library sample was stored in ITT ( 0 μL 10% IGEPAL, 0 μL 10% Tween 20, 0 mL
TE) buffer at 4oC.
Zfp57 transcript abundance was performed using the cDNA library generated for
each oocyte and embryo, with Proteasome 26S subunit, non-ATPase 4 (Psmd4) serving
as the internal control. Primers and PCR parameters can be found in Table 5-1. Secondstrand synthesis was performed using the forward primers of both Zfp57 and Psmd4, and
amplification products were then split into separate reactions for RT-PCR. Psmd4 was
chosen as an internal control transcript, since this gene has been shown to exhibit
relatively equal transcript abundance throughout all seven stages analyzed (Kouadjo et al.
2007). Amplification was performed on at least ten biological replicates for each stage
and treatment group with SYBR Green PCR supermix (BioRad) using the BioRad
Opticon Monitor Real-Time PCR machine and software. On account of primer-dimers
produced with such low amounts of cDNA, semi-quantitative analysis of gel images was
performed using Image J densitometry and ZFP57 values were normalized to those of the
internal control gene, Psmd4. Significant differences were calculated using the Student’s
t-Test statistical test between spontaneously ovulated and superovulated samples. Error
bars represent the standard error of the mean.
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Table 5- 1 List of Primers and PCR Parameters
Gene
Zfp57
Psmd4

Snrpn
Kcnq1ot1
Peg3
Peg1
H19

Primers
Forward:
Reverse:
Forward:
Reverse:

CTGGAATAGAAGTCAAACGCC
GGCTTTGTGGATTTGTGACTG
CATCTTCAGTAGGGCGTCATC
GACAGTGCCTCCTGGACCTA

Forward:
Reverse:
Forward:
Reverse:
Forward:
Reverse:
Forward:
Reverse:
Forward:
Reverse:

CACAGCTCTGACTTCCAGGAG
ATTGGTGAGCAATCCTTTGG
GACCACCCCTGCTTCTGTAA
ATCATAGCCTCCCCCTCCT
CGAGGCCTGGACCTATAGATT
CGTCTGCAGAGTTCAGATGG
TATCATGGGCTAAGGGCTTG
AGAGAGTCCCTCCCCAACAT
CCGTTTTAGGACTGCGATGT
GGGTCACAAATGCCACTAGG

PCR Program
Second strand
synthesis:
94oC 2 min
94oC 30 sec
56oC 30 sec
72oC 30 sec
94oC 10 min
SemiQuantitative
RT-PCR:
95oC 4 min
94oC 30 sec
56oC 30 sec
72oC 30 sec
45 cycles
Melting curve:
94oC 2 min
30oC 2 min
55oC-95oC,
read every 1oC
Quantitative
RT-PCR:
94oC 2min
94oC 15sec
56oC 15 sec
72oC 15 sec
45 cycles
Melting curve:
94oC 2 min
30oC 2 min
65oC-94oC,
read every 1oC

Application
RT-PCR

ChIP
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5.2.3 Western Blot Analysis
Embryos were washed in 200 μL filtered 1X PBS and were stored in pools of 10
embryos in a 0.2 mL tube at -80oC. Each embryo pool was mixed with 10 μL cell lysis
buffer (1X TE pH 7.5, 10% SDS (Bioshop)) and 1 μL proteinase inhibitor cocktail
(Sigma) and placed on ice for 10 minutes. WB dye (3 μL; 100 mM Tris-HCl, 200 mM
DTT, 4% SDS, 0.2% Bromophenol blue, 20% glycerol) was added, and the samples were
mixed and placed at 70oC for 10 minutes. Following an additional 3 minutes on ice, the
samples were loaded into a 15-well mini 8% SDS-PAGE gel and run for 1 hour. The gel
was electrotransfered to an immuno-blot PVDF membrane (BioRad) for 2 hours covered
in ice. The membrane was then blocked in 4% milk-TBST (tris-buffered saline, Tween
20) buffer at room temperature for 1 hour, and primary antibody was added in 4% milkTBST, incubated at 4oC overnight for ZFP57 and TRIM28, and at room temperature for 1
hour for histone 3 (H3) and α-tubulin. The following morning, the membrane was washed
in TBST three times, and a secondary antibody was added in 4% milk-TBST at room
temperature for 1 hour. The membrane was again washed three times in TBST, and then
incubated in Western Lightning Plus ECL solution (PerkinElmer) at room temperature
for 3-5 minutes. The membrane was then allowed to expose to an x-ray film. Intensity
measurements were made using Image J densitometry. Protein levels for ZFP57, TRIM28
and H3 were normalized to internal α-tubulin, which exhibits comparable protein levels
throughout preimplantation with a slight decrease at the blastocyst stage. Significant
differences were calculated using the Two Factor ANOVA with replication statistical
test. Error bars represent the standard error of the mean. Antibody dilutions can be found
in Table 5-2.
5.2.4 Immunocytochemistry
Immunocytochemistry was performed as described with modification (Bell et al.
2009). Following washes in M2 media (Sigma), embryos were washed in 200 μL 1X PBS
in a glass dish, then fixed in 200 μL 4% P A for 30 minutes. ollowing an additional
wash in 1X PBS, fixed embryos were either processed immediately or stored in 1X PBS
at 4oC for no more than 5 days.
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Table 5- 2 List of Antibodies
Name

Dilution

Application

Anti-ZFP57 (Abcam; ab45341)

1:200

IF

Anti-ZFP57 (Abcam; ab45341)

1. μg

WB

Anti-ZFP57 (Abcam; ab45341)

4. μL

ChIP

Anti-KAP1 (Abcam ab22553)

1:200

IF

Anti-KAP1 (Abcam; ab22553)

1 μg

WB

Anti-H3 (Abcam; ab1791)

1:5000

WB

Anti-H3 (Abcam; ab1791)

2. μL

ChIP

Anti-a-tubulin (Sigma; T5168)

1:600

WB

Normal IgG

2. μL

ChIP

Anti-rabbit IgG-Alexa488 (Invitrogen; A11008)

1:200

IF

Anti-mouse IgG-Alexa594 (Invitrogen; A11032)

1:200

IF
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ixed embryos were permeabilized for 40 minutes in 200 μL permeabilizing
buffer (0.5% Triton X-100 in 1X PBS) and then blocked overnight at 4oC in 200 μL
blocking buffer (5% normal goat serum in 1X PBS). Embryos were incubated with
primary antibody overnight in an Antibody Dilution/wash Buffer (ADB; 0.005% Triton
X and 1% normal goat serum in 1X PBS). Negative controls were incubated in ADB
alone without primary antibody. Table 5-2 lists antibody dilutions and catalogue
numbers. The following morning, embryos were washed in fresh ADB for 6-8 minutes at
37oC four times, and then incubated in secondary antibody in ADB for 1 hour at 37 oC.
Following one wash for 20 minutes in ADB with Hoechst 33342 dye (1:200 dilution) at
37oC, embryos were washed three more times for 6-8 minutes in fresh ADB at 37oC.
Embryos were placed in 4 μl M2 media in a glass-bottom culture dish under
mineral oil for imaging. Embryos were imaged at 20X magnification using the Fluoview
1000 laser scanning confocal microscope (Olympus Corp.), using the 20X objective
(Olympus super apochromat 0.75) and Fluoview V10-ASW 2.1 software. At least 20
samples were analyzed for each embryonic stage and treatment group. Fluorescence
intensity was calculated using Volocity Demo 6.3 by drawing a perimeter enclosing each
nucleus as well as each embryo and determining the sum intensity within the enclosed
areas, expressed in arbitrary units. Intensity value for nucleoplasm was calculated as sum
nuclear staining divided by volume of nuclear staining. Intensity value for cytoplasm was
calculated as sum embryo staining minus sum nuclear staining divided by volume of
embryo staining minus volume of nuclear staining. Statistical significance was
determined by the Student’s t-Test between spontaneously ovulated and superovulated
samples.
5.2.5 Micro-scale Chromatin Immunoprecipitation
Micro-scale ChIP was performed as described with modification for single
blastocyst stage embryos (O'Neill et al. 2006, Dahl & Collas 2009, Kernohan et al.
2010). Blastocysts were fixed in 200 μL 1% P A at room temperature for 8 minutes in a
glass dish. Crosslinking was stopped by placing the embryos in 200 μL 1X glycine
(125mM) at room temperature for

minutes. Embryos were then washed twice in 200 μL
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1X PBS, and transferred individually to the bottom of a sonication tube in less than

μL

1X PBS. Individual blastocysts were either processed immediately or stored at -80oC.
For solution pre-treatment, 8 μL Dynabeads-Protein G (Invitrogen) was washed
on ice with 100 μL cool Dilution Buffer in a 0.2 mL tube, and then 4.5- μL

P

antibody, 2.4 μL Histone H3 antibody or 2. μL normal IgG antibody in 100-1 0 μL
Dilution Buffer (0.01% SDS, 1% Triton-100, 2 mM EDTA, 20 mM Tris-HCl (pH8.1),
160 mM NaCl) was added. Dynabeads-Protein G-antibody was rotated at 4oC for 2 hours,
following which the supernatant was removed and Dynabeads-Protein G-antibody was
washed once with Dilution buffer for 5 minutes on rotator.
During this time,

μL acid Tyrode’s solution (Sigma) was added to each fixed

blastocyst sample on ice to remove the zona pellucida. Three μL 1% SDS lysis buffer
(1% SDS, 10mM EDTA, 50mM Tris-HCl (pH8.1)), 16 μL 1X PBS (on ice), and 1 μL
proteinase inhibitor cocktail (Sigma) was added. Samples were incubated on ice for 3-5
minutes, and then were sonicated for 13 cycles (30 sec/cycle) in cool water. Samples
were spun down after

cycles and after 13 cycles. A total of 10 μL of the sample

(chromatin lysate) was added to a 0.2 mL PCR tube, and stored at -80oC overnight as
“Input DNA”. To the remaining chromatin lysate, 180 μL Dilution buffer and 2 μL
cocktail was added, mixed and then transferred to the 0.2 mL tube containing the
Dynabeads-Protein G-antibody complex. Samples were then rotated overnight at 4oC.
The following morning, the supernatant was removed and samples were washed 2X for
P

and 1X for H3 in 200 μL low salt buffer (LSB; 0.1% SDS, 1% Triton X-100, 2

mM EDTA, 20 mM Tris-HCl (pH 8.1), 150 mM NaCl) for 4 minutes, 1X for ZFP57 and
3X for H3 in 200 μL high salt buffer (HSB; 0.1% SDS, 1% Triton X-100, 2 mM EDTA,
20mM Tris-HCl (pH 8.1), 500 mM NaCl) for 4 minutes, 1X in 200 μL TE for

minutes,

and 1X in 200 μL water for 1 minute, resulting in “ChIP DNA”. InstaGene Matrix
(BioRad; Chelex-100 beads) (40 μL) was then added to the ChIP DNA on ice. After
removing the Input DNA from the freezer, 40 μL Chelex-100 beads were added in the
same fashion. Samples were heated to 100oC for 10 minutes, and cooled to room
temperature. After the addition of 1 μL proteinase

(Sigma), the samples were incubated

at 55oC for 30 minutes, rotating in a hybridization chamber, then heated again to 100oC
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for 10 minutes. Supernatant was drawn into a non-stick tube, generating the total ChIP
DNA and Input DNA (~40 μL each).
Primers were designed to span two or three ZFP57 hexanucleotide motifs
(TGCCGC) within each DMR. Primer details and PCR parameters can be found in Table
5-1. Input DNA or ChIP DNA was added to SYBR Green PCR supermix (BioRad)
containing gene-specific primers. Amplification was performed on biological replicates
using the BioRad Opticon Monitor Real Time PCR machine and software. Percent
enrichment over input was calculated as follows: ∆Ct = (ChIP Ct) – (Input Ct), Power =
2-∆Ct, Ratio (%) = (Power / [ChIP DNA (μL) / Input DNA (μL)]) x 100%. Error bars
represent the standard error of the mean. The statistical significance of enrichment was
determined by Student’s t-test between spontaneously ovulated and superovulated
samples.
5.3

Results

5.3.1 Superovulation did not affect Zfp57 Transcript Abundance
Since we hypothesized that superovulation adversely affects a maternal effect
imprint protector protein, we first assessed Zfp57 mRNA expression in at least 10
individual spontaneously ovulated and 10 IU induced oocytes and resulting
preimplantation embryos. In spontaneously ovulated samples, Zfp57 transcript abundance
was high in oocytes and 1-cells, which is characteristic of a sequestered maternal mRNA
(Figure 5-1). At the 2-cell stage, there was a dramatic decrease in Zfp57 transcript
abundance, with transcript levels remaining low through the 4-cell, 8-cell and morula
stages, consistent with maternal ZFP57 function. Zfp57 transcript abundance increased in
blastocyst stage embryos, indicating that embryonic gene activation occurs late in
preimplantation development. Comparison of spontaneously ovulated and 10 IU induced
groups revealed no difference in transcript abundance at any stage, indicating that
superovulation does not affect transcript abundance in oocytes or embryos.
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Figure 5- 1 ZFP57 Transcript Abundance in Spontaneously Ovulated and 10 IU
Induced Oocytes and Embryos
Zfp57 transcript abundance was assessed by RT-PCR in individual oocytes and
preimplantation embryos. Ten biological replicates were performed for each stage of
spontaneously ovulated (white bars) and 10 IU induced (black bars) samples. Semiquantitative intensity measurements of each gel band were calculated using ImageJ
software, and Zfp57 transcript abundance was normalized to that of Psmd4. No
significant differences were observed between control and 10 IU induced samples. Oo,
oocytes; 1c, 1-cell; 2c, 2-cell; 4c, 4-cell; 8c, 8-cell Mo, morula; Bl, blastocyst stage
embryos.
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5.3.2 Superovulation Increased ZFP57 Protein Levels
Next, we quantified ZFP57 protein levels in oocytes and preimplantation embryos
to assess the effects of superovulation. Western blot analysis was performed on triplicate
pools of ten oocytes, 1-cells, 2-cells, 4-cells, 8-cells, morula and blastocyst stage embryos
following spontaneously and 10 IU induced ovulation using antibodies for ZFP57, as
well as Histone H3 as a control. We observed that relative ZFP57 protein levels were
equal in both groups at the oocyte and zygote stages.
However, while ZFP57 levels decrease in the spontaneous group at the 2-cell
stage, increasing at the blastocyst stage consistent with embryonic gene activation,
ZFP57 protein levels remained at levels similar to 1-cell embryos in the 10 IU induced
group at the 2-cell through to morula-stage. Higher protein levels were also present at the
blastocyst stage in the 10 IU induced group compared to controls (Figure 5-2). These
data indicate that there was greater stability of the ZFP57 protein in embryos in the
superovulated group. In comparison, no difference was observed in oocytes or embryos
for the control, Histone H3, in spontaneous ovulated and 10 IU induced groups (Figure
5-3). Since ZFP57 recruits its co-regulator TRIM28, we also analyzed TRIM28 protein
levels in spontaneous ovulated and 10 IU induced groups. We observed similar TRIM28
levels in the control and 10 IU induced samples (Figure 5-4), which is perhaps not
surprising since TRIM28 is recruited by and interacts with many zinc finger proteins.
Using a Two Factor ANOVA With Replication statistical test, a significant difference
was observed between preimplantation stages (P < 0.05) for ZFP57, TRIM28 and H3,
but no statistical difference was observed between treatment groups at any stage for any
of the proteins analyzed.
5.3.3 Superovulation Perturbs ZFP57 Protein Localization
Given the difference in protein levels, we used immunocytochemistry to
determine ZFP57 protein localization and intensity within oocytes, 1-cells (zygotes), 2cells, 4-cells, 8-cells, early morulae, late morulae and blastocyst stage in spontaneously
ovulated and 10 IU hormone treatment groups. In spontaneously ovulated oocytes,
ZFP57 is cytoplasmic in localization (Figure 5-5, 5-6).
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Figure 5- 2 ZFP57 Protein Levels in Spontaneously Ovulated and 10 IU Induced
Oocytes and Embryos
ZFP57 protein levels were assessed in oocytes and preimplantation embryos by
Western blot analysis. Three biological replicates were performed for each stage of
spontaneously ovulated (white bars, 0 IU dosage) and 10 IU induced (black bars)
samples. Intensity measurements of each band were calculated using ImageJ software,
and were normalized to α-tubulin. Relative ZFP57 protein levels were equal in both
groups at the oocyte and 1-cell stages. While ZFP57 protein levels decrease in the
spontaneous group at the 2-cell stage, they remain at levels similar to 1-cell embryos in
the 10 IU induced group, having higher protein levels at all subsequent preimplantation
stages in the 10 IU induced group compared to controls. Oo, oocytes; 1c, 1-cell; 2c, 2cell; 4c, 4-cell; 8c, 8-cell Mo, morula; Bl, blastocyst stage embryos.
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Figure 5- 3 H3 Protein Levels in Spontaneously Ovulated and 10 IU Induced
Oocytes and Embryos
Histone 3 (H3) protein levels were assessed in oocytes and preimplantation
embryos by Western blot analysis. Three biological replicates were performed for each
stage of spontaneously ovulated (white bars, 0 IU dosage) and 10 IU induced (black bars)
samples. Intensity measurements of each band were calculated using ImageJ software,
and were normalized to α-tubulin. No significant differences were observed between
control and 10 IU induced samples. Oo, oocytes; 1c, 1-cell; 2c, 2-cell; 4c, 4-cell; 8c, 8cell Mo, morula; Bl, blastocyst stage embryos.
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Figure 5- 4 TRIM28 Protein Levels in Spontaneously Ovulated and 10 IU Induced
Oocytes and Embryos
TRIM28 protein levels were assessed in oocytes and preimplantation embryos by
Western blot analysis. Three biological replicates were performed for each stage of
spontaneously ovulated (white bars, 0 IU dosage) and 10 IU induced (black bars)
samples. Intensity measurements of each band were calculated using ImageJ software,
and were normalized to α-tubulin. No significant differences were observed between
control and 10 IU induced samples. Oo, oocytes; 1c, 1-cell; 2c, 2-cell; 4c, 4-cell; 8c, 8cell Mo, morula; Bl, blastocyst stage embryos.
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Figure 5- 5 ZFP57 and TRIM28 Immunofluorescence Staining in Spontaneously
Ovulated and 10 IU Induced Oocytes and Embryos
ZFP57 (Green) and TRIM28 (Red) were co-stained by immunocytochemistry in
oocytes (OO) (n=23-25), 1-cell (1C) (n=28-31), 2-cell (2C) (n=20-29), 4-cell (4C) (n=2324), 8-cell (8C) (n=20-25), early morula (EM) (n=44-50), late morula (LM) (n=20-43),
early blastocyst (EB) and late blastocyst (LB) (n=33-33) stage embryos. Hoechst dye
(Blue) was used to stain genomic DNA. ZFP57 staining is reduced in the pronuclei of the
1-cells and the nuclei of the 4-cell stage 10 IU induced embryos, and ZFP57 cytoplasmic
staining is increased in 8-cells, early morulae, late morulae and blastocysts in comparison
to spontaneously ovulated embryos. TRIM28 staining is increased in the nuclei of 10 IU
induced 1-cells, but decreased in 10 IU induced 4-cells, late morulae and blastocysts.
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Figure 5- 6 ZFP57 Protein Localization in Spontaneously Ovulated and 10 IU
Induced Oocytes and Embryos
A) ZFP57 intensity staining in the nucleoplasm was categorized as low (light
green bars), equal (medium green bars), or high (dark green bars) in nucleoplasm
compared to cytoplasm of each sample. Each category was calculated as a percentage of
total samples in spontaneous (0) and 10 IU induced (10 IU) oocytes (Oo), and 1-cell (1c),
2-cell (2c), and 4-cell (4c) stage embryos. B) ZFP57 intensity staining in the cytoplasm
was categorized as low (light purple bars), medium (medium purple bars), or high (dark
purple bars) cytoplasmic staining. Each category was calculated as a percentage of total
samples in spontaneous (0) and 10 IU induced (10 IU) 8-cell (8c), early morula (EM),
late morula (LM), and blastocyst (Bl) stage embryos.
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In 16/28 (57%) zygotes, ZFP57 was found in the pronuclei in addition to the
cytoplasmic staining. In control 2-cell stage embryos, there was low nuclear staining in
15/20 (75%) compared to cytoplasmic levels. However, at the 4-cell stage, ZFP57
nuclear intensity levels were higher than cytoplasmic levels in 23/24 (96%) control
embryos. ZFP57 continued this dual cytoplasmic and nucleoplasmic staining in the 8-cell
stage, with 24/25 (96%) having medium or low cytoplasmic staining. In the early morula
stage of development, there was a reduction in cytoplasmic staining of ZFP57 in all 44
(100%) embryos, with primarily nuclear only staining in all 20 (100%) late morulae and
34 (100%) blastocysts.
In comparison to controls, 10 IU induced oocytes also exhibited ZFP57 staining
in the cytoplasm. While overall staining intensity between the two zygotic groups did not
differ, examination of individual embryos showed that while 16/28 (57%) of spontaneous
zygotes possessed pronuclear staining, 0/31 (0%) 10 IU induced zygotes showed staining
in the pronuclei. At the 2-cell stage, staining levels between the two groups remained
unchanged, having 15/20 (75%) spontaneously ovulated and 20/29 (70%) induced
ovulated 2-cell stage embryos showing lower staining levels in nucleoplasm compared to
cytoplasm. Intriguingly, a statistically significant decrease in nuclear staining was
observed in the 10 IU induced 4-cell stage embryos (P < 0.01 in nucleoplasm).
Examination of individual embryos showed that while 23/24 (96%) of spontaneously
ovulated 4-cell embryos showed higher nuclear intensity levels than cytoplasmic levels,
this was only observed in 3/23 (13%) of 4-cell stage embryos in the 10 IU induced group.
The level of staining in both the cytoplasm and the nucleoplasm of the 8-cell stage
embryos was significantly higher in the 10 IU induced group (P < 0.001 in the
nucleoplasm, P < 0.001 in the cytoplasm), having 14/20 (70%) superovulated embryos
with high cytoplasmic staining compared to 1/25 (4%) in spontaneous embryos. This
observation carried through to the early morula stage (P < 0.001 in the nucleoplasm, P <
0.001 in the cytoplasm), where the number of embryos with strong cytoplasmic staining
was higher in 33/50 (66%) of the 10 IU induced embryos compared to 0/44 (0%) of the
unstimulated controls. By the late morula stage, 10 IU induced embryos exhibited
significantly higher cytoplasmic staining in comparison to control embryos (P < 0.05 in
the cytoplasm). Embryos in the spontaneously ovulated late morulae group exhibited high
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nucleoplasmic ZFP57 staining and low cytoplasmic staining, having 0/20 (0%) remaining
high in the cytoplasm, while superovulated late morulae showed 11/43 (26%) remaining
high in the cytoplasm. By the blastocyst stage however, no significant difference was
observed between cytoplasmic and nuclear staining of ZFP57 with respect to localization
or intensity (Figure 5-5, 5-6). Thus, In comparison to controls, 1- and 4-cell embryos in
the high hormone-treated group possessed primarily cytoplasmic localization of ZFP57.
Furthermore, 8-cell, early morula and late morula stage embryos displayed aberrant
cytoplasmic staining. This indicates that superovulation leads to aberrant ZFP57
localization with delayed or defective nuclear import until the 8-cell stage combined with
increased ZFP57 protein stability.
5.3.4 Superovulation Alters TRIM28 Protein Intensity in the Nucleus
ZFP57 was co-stained with TRIM28 in each oocyte and embryo and examined by
immunofluorescence. TRIM28 staining was undetectable in both spontaneous and 10 IU
induced oocytes (Figure 5-5). In 1-cell zygotes, TRIM28 was localized to both parental
pronuclei, and remained in the nuclei at all subsequent preimplantation stages. Nuclear
staining in the 10 IU induced group was statistically higher than controls at the 1-cell
stage (P < 0.01). By the 4-cell stage, TRIM28 nuclear staining was lower in the 10 IU
induced group compared to the spontaneous ovulated 4-cell stage group. Similarly, lower
TRIM28 nuclear staining was present in late morula and blastocysts in the 10 IU induced
group compared to control embryos (P < 0.01). In individual blastomeres undergoing
mitosis, TRIM28 staining is observed throughout the cytoplasm.
5.3.5 ZFP57 Binding is Reduced at Imprinted DMRs
The above analyses address the global effects of superovulation on ZFP57. To
directly assess the effects of superovulation on ZFP57 activity we investigated ZFP57
binding at the ZFP57 hexanucleotide motif(s) within the Snrpn, Kcnq1ot1 and H19 ICRs,
and at the Peg3 and Peg1 DMRs. Micro-scale chromatin immunoprecipitation was
performed on 20-24 individual blastocysts in the spontaneously ovulated and 10 IU
induced groups. Histone H3 was also examined at each locus as a control. Compared to
the spontaneously ovulated group, a significant reduction in ZFP57 enrichment was
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observed at all five imprinted domains in the 10 IU induced group (Figure 5-7). In
contrast, no significant difference was observed for H3 binding at ICRs/DMRs between
blastocysts in spontaneously ovulated and 10 IU groups (Figure 5-8).
5.4

Discussion
Imprint maintenance in the early embryo is susceptible to ART manipulations,

including superovulation (Market-Velker et al. 2010b, El Hajj et al. 2011). Yet, imprint
acquisition in the oocyte is unaffected (Anckaert et al. 2009a, Denomme et al. 2011).
Thus, we hypothesized that a maternal factor, accumulating in the oocyte as exogenous
hormones are applied, is instead affected and can no longer properly maintain genomic
imprinting post-fertilization.
In this study, we set out to determine whether superovulation affected the
maternal factor ZFP57, known to play an essential role in genomic imprinting regulation.
In the 10 IU induced group of embryos, we observed an increase in ZFP57 protein levels
initiating at the 2-cell stage. At the same time, ZFP57 was mislocalized away from the
nucleus, particularly at the superovulated 4-cell stage. The majority of increased
cytoplasmic staining was opaque and clouded, however some embryos from both
treatment groups displayed a punctate staining, which occurred more frequently in the 10
IU induced embryonic group (Supplementary Figure 5-1s, Appendix 2, (Denomme &
Mann 2013), reminiscent of autophagy activity.
However, while protein levels were increased, we observed a significant decrease
in ZFP57 protein enrichment at all five imprinted domains examined (Kcnq1ot1, Snrpn,
Peg3, Peg1, H19). As protein levels were higher in the 10 IU induced group at multiple
stages of development, while transcript abundance was unaffected, it is possible that
hormone induction alters ZFP57 protein folding. This could generate increased protein
stability, but at the same time affect access to the critical zinc fingers or KRAB box
domain involved in DNA methylation maintenance.
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Figure 5- 7 ZFP57 Protein Enrichment at Imprinted Loci in Spontaneously
Ovulated and 10 IU Induced Blastocysts
ZFP57 protein enrichment at imprinted DMRs was assessed by micro-scale chromatin
immunoprecipitation in individual blastocysts. At least twenty biological replicates
(n=20-24) were performed for each imprinted loci in spontaneously ovulated (white bars)
and 10 IU induced (black bars) blastocysts. Significant differences were calculated using
the Student’s t-Test statistical test, (a, P < 0.001; b, P < 0.05).

134

Figure 5- 8 H3 Protein Enrichment at Imprinted Loci in Spontaneously Ovulated
and 10 IU Induced Blastocysts
Histone 3 (H3) protein enrichment at imprinted DMRs was assessed by microscale chromatin immunoprecipitation in individual blastocysts. At least twenty biological
replicates (n=20-24) were performed for each imprinted loci in spontaneously ovulated
(white bars) and 10 IU induced (black bars) blastocysts. Significant differences were
calculated using the Student’s t-Test statistical test.
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Alternatively, it may compromise the nuclear localization signal (NLS), including
the many phosphorylation sites and other necessary post-translational modifications
(Alonso et al. 2004), affecting the ability for ZFP57 to be properly and timely transported
into the nucleus. Going forward, we hypothesize that delayed or defective ZFP57 nuclear
localization at the 4-cell stage leads to passive loss of imprinted DNA methylation. This
may result in failure to recruit TRIM28 and in turn DNMT1. We observed lower levels of
TRIM28 in 10 IU induced 4-cell embryos. This compromised ability to protect imprinted
genes from global demethylation processes would be expected to lead to a passive loss of
imprinted methylation initiating at the 8-cell stage. In alignment with this premise, El
Hajj et. al. examined 7.5 IU induced 16-cell stage embryos and reported loss of Snrpn
maternal methylation in 2/10 mouse embryos, loss of H19 paternal methylation in 2/10
embryos, and gain of H19 maternal methylation in 1/10 embryos (El Hajj et al. 2011).
Aberrant loss and gain of methylation was observed in a greater number of embryos and
imprinted loci by the blastocyst stage (Market-Velker et al. 2010b). However, since
ZFP57 binds to a methylated recognition sequence, it is possible that DNA methylation
maintenance is compromised prior to the 4-cell stage. Reduced imprinted methylation
would lead to reduced enrichment of ZFP57 at ICRs. Resolving these possibilities will
require investigations into when imprinted methylation is lost during preimplantation
development following superovulation.
Targeted deletion and mating strategies were previously used to resolve the roles
of maternally derived and embryonically produced ZFP57 in the early embryo (Li et al.
2008). The authors reported embryonic lethality by midgestation upon deletion of both
forms. Ablating embryonic ZFP57 alone produced partial neonatal lethality, but deletion
of maternal ZFP57 alone was not lethal due to embryonic ZFP57 rescue (Li et al. 2008).
During preimplantation development, maternally derived Zfp57 is the sole source of this
protein, demonstrated in our results by RT-PCR analysis, as well as through expression
arrays (Zeng et al. 2004). Maternal ZFP57 deficiency resulted in hypomethylation of
Snrpn at embryonic day 3.5, confirming the status of ZFP57 as an essential maternal
effect factor. However, embryonic ZFP57 was able to rescue the reduced methylation
levels by day 13.5 (Li et al. 2008).
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The same study demonstrated that maternal ZFP57 is required for the
establishment of methylation imprints at Snrpn in the oocyte (Li et al. 2008). However,
germline methylation acquisition occurred normally at other DMR regions examined,
Peg1, Peg3, and Peg5. Effects from assisted reproductive technologies on ZFP57
function likely do not present themselves in the oocyte, as we and others have described
no effect on proper imprint acquisition at maternally imprinted domains from
superovulation (Anckaert et al. 2009a, Denomme et al. 2011), in vitro oocyte maturation
in culture (Anckaert et al. 2009a, Anckaert et al. 2009b, Anckaert et al. 2010), or oocyte
vitrification (Trapphoff et al. 2010). Similarly, total Zfp57 mRNA levels in mature
oocytes were comparable following in vitro follicle culture and in vivo stimulated
development (Anckaert et al. 2013). Although, a second study reports a significant
decrease in Zfp57 transcripts upon administration of hCG (Agca et al. 2013) compared to
pre-ovulatory levels in control oocytes. While more studies are required to delineate
Zfp57 transcript levels throughout oogenesis and upon meiotic resumption, there does not
appear to be a difference between induced ovulation and spontaneous ovulation.
The partial loss of DNA methylation observed in blastocyst stage embryos at
individual genes and the stochastic nature of this loss among blastocysts from stimulated
mothers (Market-Velker et al. 2010b) and cultured embryos (Market-Velker et al. 2010a)
is reminiscent of previously reported stochastic loss between embryos with maternal
Zfp57, Trim28 and Dnmt1 deletion (Hirasawa et al. 2008, Li et al. 2008, Messerschmidt
et al. 2012). While ZFP57 and TRIM28 have demonstrated roles as protectors, they did
not function at all imprinted genes. Maternal and embryonic ZFP57 deletion did not lead
to H19 DNA methylation loss (Li et al. 2008); and TRIM28 deletion did not lead to Peg3
DNA methylation loss (Messerschmidt et al. 2012). One possible explanation for these
differences is that sufficient numbers of embryos may not have been examined.
A recent study in mouse ES cells reported the functional interchangeability
between human and mouse ZFP57 in maintaining DNA methylation at the Snrpn, Zac1,
and Dlk1-Dio3 imprinted loci (Takikawa et al. 2013). This functional equivalence
suggests that the human ZFP57 protein may also be susceptible to ovarian stimulation or
other ARTs techniques and may affect genomic imprinting maintenance during human
embryonic preimplantation development.
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Interestingly, ZFP57 mutations have recently been shown to be the causative
factor in 5% of Transient Neonatal Diabetes Mellitus 1 (TNDM1) patients. This disease
arises from hypomethylation at the TNDM1 locus, which lies within the imprinted
promoter of the major candidate gene PLAGL1/ZAC1 (Mackay et al. 2008). Additional
hypomethylation is reported at maternally imprinted loci PEG3 and GRB10, with variable
and partial hypomethylation at PEG1, KCNQ1OT1 (Mackay et al. 2008), as well as
NESPAS/GNAS (Boonen et al. 2013) in some patients. In addition to transient neonatal
diabetes, the key clinical features in patients with TNDM1 can include intrauterine
growth retardation, macroglossia, heart defects, and developmental delay. These variable
phenotypes are reminiscent of the known imprinting disorders BWS and SRS (Elliott et
al. 1994, Kotzot et al. 1995, Weksberg et al. 2001, Eggermann et al. 2010). However, no
correlation has yet been described between ZFP57 mutations and these known imprinting
disorders (Spengler et al. 2009, Boonen et al. 2012).
For decades, ART techniques have been correlated with imprinting errors.
However, the pathway to these errors is unclear, and the regulatory proteins directly
disrupted by these manipulations are still unknown. The recent discovery of numerous
maternal effect genes has brought new insight into genomic imprinting regulation. In this
study, we have begun to shed light on the pathway affected by assisted reproductive
technologies. As the significance of ZFP57 in imprinting regulation has only recently
been reported, and its susceptibility to ovarian stimulation is highlighted in this study,
further studies should be performed in detail with human IVF clinics to ensure safe
procedures.
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6 CHAPTER 6: Discussion
6.1

Opening Discussion
Genomic imprinting is a transcriptional regulatory process controlling monoallelic

gene expression (Bartolomei & Ferguson-Smith 2011). This dynamic process relies on
epigenetic modifications such as DNA methylation to mark, or “imprint”, and silence one
of the two parental alleles. Mechanisms must operate within both developing parental
germ cells and in the preimplantation embryo to first establish and then maintain these
allele-specific differential marks. The question of gamete and embryo predisposition to
infertility- and ART-induced epigenetic defects is of critical importance to maximize the
safety of fertility treatments. Therefore, identifying the factors involved in the imprinting
regulatory pathway, and understanding how they are affected by assisted reproduction,
will help reduce the occurrence of imprinting disorders in the ART population.
The field of genomic imprinting has been limited by the technical difficulties
involved in investigating such small amounts of genetic material, and in the past, studies
were carried out using pools (often hundreds) of oocytes or preimplantation embryos.
Work from my research group has substantially furthered the field by facilitating DNA
methylation analyses in individual blastocysts (Velker et al. 2012) and in individual
oocytes (Denomme et al. 2012b). We now have the ability to evaluate the effects of
infertility and ARTs at the single cell level, identifying the frequency of perturbations
among samples as well as among imprinted loci within individual samples. In addition,
we have revolutionized conventional Western blot and chromatin immunoprecipitation
(ChIP) protocols to examine small cell numbers, specifically ChIP analysis using single
blastocysts and Western blot analysis using pools of ten oocytes. Importantly, this new
level of investigation is approaching relevancy for application in the human clinic.
Using these modified assays, the experiments within this thesis provide a
comprehensive analysis of the maternal control of genomic imprinting at the single
oocyte and preimplantation embryo level and uncover a part of the molecular mechanism
that is disrupted by ARTs. I examined the effects of maternal infertility and subfertility
on imprint acquisition in growing oocytes. I also examined the effects of maternal
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ovarian stimulation as an ART treatment on imprint acquisition in MII oocytes. Finally, I
investigated the effects of maternal ovarian stimulation on the mechanisms of imprint
regulation via the maternal factor ZFP57.
Work presented in this thesis has brought new insights into the maternal control
of genomic imprinting regulation: (a) maternal infertility can predispose imprinted loci,
namely the late-acquiring Peg1 locus, to imprinting errors in the female gamete, (b) in
comparison, ovarian stimulation does not disrupt the process of imprint acquisition in the
female gamete; (c) instead, ovarian stimulation disrupts the protein localization, protein
abundance, and protein binding (at imprinted loci) of the maternal effect factor ZFP57, a
specific and central component of the imprinting regulatory pathway.
6.2

Pathways Leading to Imprinting Instability
Multiple avenues of investigation are required to delineate the effects of infertility

and assisted reproduction on epigenetic gene regulation. Foremost, studies are required to
determine the molecular and cellular mechanisms giving rise to epigenetic errors
following maternal environmental perturbations. This includes the identification of
maternal factors involved in epigenetic regulation during embryo development.
Adaptation or stress induced by a suboptimal fertile environment, or acceleration of
oocyte maturation or recovery of atretic oocytes by superovulation, can all affect the
ability of the oocyte to properly synthesize and store sufficient amounts of maternal
factors (Li et al. 2010).
6.2.1 Maternal Factors Regulating Genomic Imprinting are disrupted by ARTs
Recent reports have begun to shed light on the roles played by maternal factors
during embryo development, namely during the oocyte-to-embryo transition period as
whole genome reprogramming occurs. This has brought new insight into the mechanisms
involved in genomic imprinting regulation, where the recruitment of specialized
maintenance complexes to imprinted regions is necessary to ensure epigenetic integrity,
both directly after fertilization and throughout cleavage-stage development. DPPA3 is
one protein identified to protect imprinted genes from active DNA demethylation, while
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the triumvirate of proteins, ZFP57, TRIM28, and DNMT1, appears to provide protection
from passive DNA demethylation during preimplantation development.
Understanding how ARTs may disrupt maternal effect products that regulate
imprint maintenance will be essential for maximizing the safety of their procedures and
ensuring healthy embryonic development. In this thesis, I characterized the maternal
effect product ZFP57 throughout preimplantation development under in vivo conditions,
and identified how it is susceptible to ARTs. I demonstrated that ZFP57 protein levels
were markedly higher in superovulated embryos in comparison to spontaneous controls at
the 2-cell stage and subsequent preimplantation stages. As no change was noted in Zfp57
transcript abundance, it is possible that protein stability is affected by superovulation.
ZFP57 protein localization undergoes a cytoplasmic to nucleoplasmic transition during
preimplantation development, and this was disrupted and/or delayed in stimulated
embryos, particularly evident at the 4-cell stage. This misregulation of ZFP57 preceded a
significant decrease in protein enrichment at imprinted ICRs in blastocysts, proposing a
mechanism for imprint methylation maintenance loss following ARTs. My current model
utilizing this data postulates that if ZFP57 cannot enter the nucleus at the appropriate
stage, it cannot recruit its co-factor TRIM28 and the repressive complexes to imprinted
regions. The ability to protect imprinted genes from global demethylation processes is
compromised, and imprinted DNA methylation maintenance cannot be sustained, leading
to a passive loss of methylation initiating at the 8-cell stage. To support this, aberrant loss
of Snrpn and H19 methylation was reported in some alleles of superovulated 16-cell
embryos (El Hajj et al. 2011) and a greater number of embryos and imprinted loci were
affected by the blastocyst stage (Market-Velker et al. 2010b). By elucidating the effects
of superovulation on the imprint regulator ZFP57, I have uncovered an essential
component of the molecular mechanism that is disrupted by ARTs.
6.2.2 Infertility Predisposes Imprinting Loci to Errors
The increased incidence of imprinting disorders in the ART population has led to
the question of whether infertility alone predisposes embryos to imprinting errors. To
imitate female subfertility, I used ERβ deletion mice with a compromised endocrine
signaling pathway. However, normal DNA methylation acquisition was observed at
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Snrpn, Peg3, and Peg1 in oocytes from these Esr2-deficient females. In comparison, as a
means of simulating female infertility, I used connexin37 deletion mice to determine
whether compromised gap junctional communication between the oocyte and the
cumulus cells would disrupt de novo DNA methylation acquisition (Denomme et al.
2012a). Connexin37 deficiency resulted in loss or delayed methylation acquisition at the
late-acquiring gene Peg1, suggesting that stored methyl donors or other metabolites
normally transported from granulosa cells to the oocyte may have been exhausted during
oocyte growth in these Gja4-deficient females.
Barriers to a thorough evaluation of human infertility exist, and so validating a
link between female infertility and genomic imprinting in human oocytes is proven
difficult. However, numerous studies have reported a predisposition to imprinting errors
upon male infertility in human sperm (Manning et al. 2001, Kobayashi et al. 2007,
Marques et al. 2008, Boissonnas et al. 2010, Minor et al. 2011, Sato et al. 2011). The
principal question, however, is whether oocyte- or sperm-imprinting errors are
transmitted to offspring. An analysis of aborted conceptuses from males with moderatelyto-severely low sperm concentration reported 7/17 (41%) cases with abnormal DNA
methylation in the aborted conceptus and the identical alterations present in the paternal
sperm. (Kobayashi et al. 2009), indicating that imprinting errors from the gametes can be
transmitted to the developing embryo.
Taken together, impaired fertility in the gametes can predispose imprinting loci to
imprinting errors. Further studies are required to delineate the process in which this
occurs, and whether maternal factors are involved.
6.2.3 ARTs Predisposes Imprinting Loci to Errors
Paramount to assisted reproduction is that the timing of ARTs coincides with
critical epigenetic events during gametogenesis and early embryogenesis. Understanding
how ARTs cause epigenetic disruption is crucial for maximizing their efficacy and safety.
In both BWS and AS human imprinting disorders, patients have been conceived by
ovarian stimulation alone, having no other form of ARTs used (Chang et al. 2005,
Ludwig et al. 2005). This led to the investigation of ovarian stimulation as a potential
imprinting disruptor. These disorders typically exhibit aberrant loss or gain of maternal

149
methylation at their imprinting control regions (DeBaun et al. 2003, Gicquel et al. 2003,
Maher et al. 2003, Orstavik et al. 2003). Because exogenous hormones are administered
during oocyte development, I hypothesized that the acquisition of imprints would be
disrupted in oocytes. Surprisingly, Snrpn, Kcnq1ot1 and Peg3 were hypermethylated,
while H19 was hypomethylated, regardless of low or high hormone treatment (Denomme
et al. 2011), indicating no effect. A single oocyte (1/125) from the 10 IU hormone group
contained a hypomethylated Kcnq1ot1 ICR. I attributed this to a spontaneous loss of
maternal methylation, cumulus cell contamination, or possibly a rare imprinting error
predisposed by ovarian stimulation. With this caveat in mind, the study suggests that
ovarian stimulation does not greatly impact DNA methylation acquisition.
Molecular evidence from an earlier mouse study showed a higher occurrence of
abnormal global methylation patterns as early as the 2-cell stage in embryos derived from
superovulated females (Shi & Haaf 2002). At imprinted loci, aberrant loss or gain of
DNA methylation was observed in superovulated 16-cell stage embryos (El Hajj et al.
2011). Likewise, a study from my research group reported a greater number of embryos
with loss or gain of DNA methylation at multiple imprinted genes by the blastocyst stage
(Market-Velker et al. 2010b). Thus, taken together, these studies indicate that
superovulation instead leads to imprinting maintenance errors post-fertilization.
Earlier studies from my research group indicated that a second ART technique, in
vitro embryo culture, also compromises imprint maintenance when analyzed at the
blastocyst stage of development (Market-Velker et al. 2010a). In a subsequent study on
developmental rates of embryos in culture, imprint maintenance mechanisms were
disrupted by rapid development in culture prior to the 8-cell stage, producing imprinting
errors at subsequent embryonic stages. Greater numbers of embryos with fast rates of
development had Snrpn and H19 loss of methylation compared with those that developed
slower in culture (Market Velker et al. 2012). As a result, I propose that different ARTs
techniques, including those that take place during oogenesis and those that take place
during embryogenesis, converge on a common imprinting regulatory pathway involving
maternal-effect genes.
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6.2.4 Complexity of Multiple ARTs and Infertility: Relation to the Human Clinic
In human clinics, multiple ARTs are employed, and so it is difficult to discern the
origin of imprinting anomalies. Moreover, ethical and social limitations of using human
embryos prevent a thorough evaluation of ARTs techniques, especially the inability to
acquire and analyze control oocytes and embryos. With this in mind, several groups used
animal models to conduct research distinguishing the effects of various ARTs (Fauque et
al. 2007, Rivera et al. 2008, Market-Velker et al. 2010a). Taken together, these studies
demonstrate an additive effect with combined ART procedures.
Human embryos produced via ARTs are also the product of underlying
infertility/subfertility. This has led to questions regarding the origin of epigenetic
instability; does it come from underlying infertility in gametes/embryos, does it come
from gamete/embryo manipulations, or does it come from a combination of infertility and
ARTs. The relationship between impaired fertility, ARTs and epigenetic stability is
unquestionably complex. However, the possibility exists that ARTs and infertility may
disrupt the same mechanistic pathways involving maternal-effect genes that lead to
epigenetic errors. If this is the case, perturbations induced by infertility may be
exacerbated by gamete or embryo manipulation, similar to combined ART treatments.
This would be consistent with ART-associated BWS children where variable ART
procedures were reported to be used, including different embryo culture media, day of
transfer, and specific ART method used (IVF, ICSI), in addition to the cause of infertility
(Gicquel et al. 2003, Chang et al. 2005).
Overall, if embryo response to infertility and ARTs is stochastic, then the leading
question remains: which embryo will be least compromised by ovarian stimulation, or
other manipulations. As fast rates of development in culture correlate with loss of
imprinting, it was proposed that embryos that adapt or respond the least to their
suboptimal environment will likely develop in the most normal fashion (Baumann et al.
2007, Leese et al. 2007, Market Velker et al. 2012). Modification of ARTs techniques
that minimize the need for increased adaptation will likely have a corresponding decrease
in epigenetic perturbations and thus, increased overall health of the embryo. Thus,
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limiting ovarian stimulation protocols through single oocyte retrieval and single embryo
transfer is one way to minimize effects of stress by ARTs.
6.3

Experimental Limitations
Research on individual oocytes and embryos provides us with information at the

single cell level, emphasizing the stochastic nature of genomic imprinting loss and
minimizing any biases based on pools. Nevertheless, working with this minute amount of
material can be limiting in the types of experiments performed, and statistical analyses
can be problematic. Significant results by quantitative analyses can be particularly
difficult to obtain at the later stages of preimplantation development, where the number
of blastomeres varies between embryos as they develop at different rates. The variability
in ZFP57 protein levels between replicates in the Western Blot experiment may have
concealed statistical significances that would otherwise be observed in larger pools of
samples. In my examination of Zfp57 transcript abundance, unavoidable primer-dimers
were produced with such low amounts of cDNA, preventing quantitative analysis
between treatment groups through conventional ∆Ct methods. While my research group
has modified the bisulfite mutagenesis, Western blot and micro-scale ChIP assays to
accommodate small cell numbers, other techniques like co-immunoprecipitation, mass
spectrometry, and high-performance liquid chromatography (HPLC) are not yet
available. These experiments would be useful in understanding protein-protein
interactions, like those with ZFP57, in the early embryo. Cell culture techniques using ES
cells, TS cells and XEN cells can overcome many of these experimental limitations
driven by cell number requirements, but do not provide information for the earlier stages
in embryonic development that are so dynamic and critical to understand.
6.4

Future Directions

6.4.1 Maternal Infertility
Impaired fertility can predispose imprinting loci in the gametes to imprinting
errors. However, further studies are required to delineate the process in which this occurs,
namely the molecular mechanisms leading to imprinting perturbations. I proposed that
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CX37-null oocytes have exhausted their methyl donors during oocyte growth, preventing
de novo methylation at late-acquiring genes like Peg1. Further studies are required, like
HPLC on pools of pre-antral stage oocytes, to determine if there is a reduction in sadenosylmethionine (SAM), the primary methyl donor in oocytes. Otherwise, as CX37null oocytes arrest at the pre-antral stage of oogenesis, I cannot currently decipher
between a disruption and a delay in methylation acquisition at Peg1.
Studies are also required to determine whether female subfertility/infertility, like
those originating from impaired endocrine signaling and intercellular communication
during oogenesis have an effect post-fertilization on imprint maintenance in the embryo.
As CX37-deficiency leads to infertility, the current mouse model does not facilitate these
studies. However, utilizing heterozygote females or shRNA-mediated Gja4 RNA
depletion would possibly promote oocyte maturity and fertilization and lead to
investigations on imprint maintenance post-fertilization. As ERβ-deficient oocytes
acquired de novo DNA methylation without errors, it is important to discern if the effects
manifest post-fertilization, similar to those observed with superovulation. Furthermore, to
clarify if infertility and ARTs converge on a common imprinting regulatory pathway, it is
necessary to elucidate the effects of infertility/subfertility on the regulation of maternaleffect factors like ZFP57 during oogenesis and preimplantation development.
Finally, to truly delineate the risk of epigenetic errors resulting from infertility vs.
ARTs in the human population, investigations are required on gametes, embryos and
children from couples seeking ARTs in the absence of compromised fertility such as for
preimplantation genetic diagnosis and same-sex couples.
6.4.2 Ovarian Stimulation
While my study demonstrates that maternal DNA methylation acquisition at
imprinted loci is not disrupted by superovulation, loss of methylation maintenance is
observed post-fertilization. This has been reported at the 16-cell stage (El Hajj et al.
2011) and the blastocyst stage (Market-Velker et al. 2010b). However, it is currently
unknown at what stage DNA methylation maintenance is initially lost. Resolving this will
require investigations at each preimplantation stage following superovulation.
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DNA methylation has been correlated with allelic expression of many imprinted
genes (Verona et al. 2003). However, studies on the effects of ovarian stimulation alone
on imprint expression are limited (Fortier et al. 2008), and should be investigated in more
detail in the preimplantation embryo and at multiple post-implantation stages to
determine if and when loss of imprinted methylation results in a corresponding loss of
imprinted expression.
Human oocytes may respond differently to ovarian stimulation in comparison to
animal models. As an increased proportion was reported to exhibit a loss or gain of DNA
methylation (Sato et al. 2007, Khoueiry et al. 2008) they may be more prone to
epigenetic errors and/or encounter more stressors. Future studies should be directed
toward larger numbers of human oocytes to fully elucidate the effects. Additionally, to
truly delineate the risk of imprinting errors resulting from ARTs, and specifically ovarian
stimulation, investigations are required on control unstimulated human gametes and
embryos.
6.4.3 Maternal Effect Factors
Perturbations to the maternal environment can predispose the oocyte to imprinting
errors, likely manifesting post-fertilization. ZFP57, a key player in the regulation of
genomic imprinting, is significantly misregulated by ovarian stimulation. Based on
observations from my research group following superovulation and in vitro embryo
culture on imprinted methylation at the blastocyst stage (Market-Velker et al. 2010a,
Market-Velker et al. 2010b, Market Velker et al. 2012), I propose that different ARTs
techniques converge on a common imprinting regulatory pathway involving maternaleffect factors. Thus, to support this hypothesis, it is imperative to investigate whether
ZFP57 responds in a similar manner to alternative ARTs procedures including in vitro
oocyte maturation and in vitro embryo culture.
My current model postulates that the delayed or defective ZFP57 nuclear
localization at the 4-cell stage prevents imprint maintenance and leads to a passive loss of
imprinted DNA methylation, initially occurring at the following 8-cell stage. However it
is possible that DNA methylation maintenance is compromised by superovulation prior to
the 4-cell stage. Since ZFP57 binds to a methylated recognition sequence, reduced
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imprinted methylation would also explain the observed reduced enrichment of ZFP57 at
ICRs in the blastocyst. To resolve these possibilities, investigations are again required to
determine what stage imprinted DNA methylation maintenance is initially lost during
preimplantation development following superovulation, as well as micro-scale ChIP
analyses at each preimplantation stage to determine when ZFP57 protein enrichment is
initially reduced at imprinted ICRs.
The maternal factor ZFP57 is only one of many proteins involved in imprint
maintenance, and many questions remain, as the pathway from hormone induction to
ZFP57 misregulation is still unknown. Superovulation accelerates the growth rate of
ovarian follicles, and may erroneously rescue and promote ovulation of atretic oocytes.
This accelerated growth has been thought to result in a decrease in maternal mRNA
stores, which would fall below a necessary threshold for maintenance at imprinting loci
prior to embryonic Zfp57 gene activation. Yet, Zfp57 transcript abundance following
superovulation appears to be equal to that of spontaneously ovulated oocytes and
embryos. If superovulation does not affect the synthesis and storage of Zfp57 transcripts
in the oocyte, it is possible that hormone induction compromises ZFP57 protein folding,
affecting the critical zinc fingers that physically bind to the methylated DNA, or the
KRAB box domain involved in recruiting TRIM28 and other repressive proteins to
promote maintenance of DNA methylation. Experimental techniques that enable
evaluation of protein folding currently require large quantities of concentrated protein
and would be difficult to evaluate in preimplantation embryos, where the discrepancy is
observed.
Superovulation may alternatively compromise the nuclear localization signal
(NLS) or the numerous phosphorylation and glycosylation sites affecting the ability for
ZFP57 to be properly and timely transported into the nucleus. It may instead affect a
maternal factor(s) upstream of ZFP57 in the imprint regulatory pathway. As ZFP57 does
not enter into the nucleus at both the 1-cell and the 4-cell stage in many superovulated
embryos, attractive candidates are the nuclear transport proteins, a number of which are
maternally provided. The transport of proteins from the cytoplasm into the nucleus
through the nuclear pore complex is an active process mediated by members of the
importin/karyopherin family (Lusk et al. 2007). RanBP5 is a nuclear transport shuttle
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protein that has previously been shown to bind to DPPA3 and mediate its transport into
the maternal pronucleus of the zygote, protecting against active DNA demethylation
(Nakamura et al. 2007). It is likely that either this protein or a related importin protein
binds to the NLS locus on ZFP57 and is required for the transport of ZFP57 into the
nucleus during preimplantation development. Interestingly, the embryonic transcript of
RanBP5 is activated at the 8-cell stage (Zeng et al. 2004), which corresponds to the first
stage of increased ZFP57 localization in the nuclei of superovulated embryos. If the
maternal RanBP5 protein is affected by superovulation, it may not be able to properly
transport its cargo proteins into the nucleus prior to the 8-cell stage. Future studies should
begin with co-immunoprecipitation of ZFP57 and RanBP5 to determine if there is an
interaction in the early embryo. Additional studies on Ranbp5 transcript abundance by
RT-PCR as well as protein localization by immunofluorescence and protein abundance
by Western blot will elucidate the effects of superovulation on the properties of this
protein. One caveat is that RanBP5 may prove to be unaffected by superovulation or may
not be the nuclear importer of ZFP57. Future experiments should also involve
immunoprecipitation and mass spectrometry to identify all proteins that interact with
ZFP57, although this experiment may not currently be feasible in the early embryo and
may require the use of ES cells. Similar studies would then be required to determine their
role in imprint maintenance, as well as how they respond to superovulation and other
techniques during preimplantation development.
Work in this thesis has only begun to decipher the pathway involved in imprint
regulation and how it is affected by ARTs. ZFP57 and TRIM28 have demonstrated roles
as protectors, however they are not reported to function at all imprinted genes. In
addition, they do not account for aberrant gain of DNA methylation. My research group
previously reported a gain of maternal DNA methylation for the normally unmethylated
maternal H19 allele in four out of ten 10 IU induced blastocysts (Market-Velker et al.
2010b). The repressive proteins involved in protection against demethylation currently do
not explain this gain of DNA methylation observed following ARTs. Thus, further
studies are required to delineate additional mechanisms that act as protectors, against
both aberrant demethylation and aberrant methylation, involved in the regulation of the
genomic imprints. H1foo, Zar1, Npm2, Nlrp5, and Setdb1 all have been implicated in
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epigenetic regulation during the oocyte-to-embryo transition and are primary candidates
(Burns et al. 2003, Maeda et al. 2008, Fernandes et al. 2012). However, no direct link
between these maternal factors and genomic imprint maintenance has been described to
date. As mitochondria generated in the oocyte is the sole source of acetyl groups, methyl
groups and ATP (which powers chromatin-remodeling complexes) in the preimplantation
embryo, it may also contribute to the unknown pathway involved in imprint regulation.
Identification of these additional regulators is critical to understanding the complete
mechanism of genomic imprinting in the early embryo, and elucidating the pathway from
hormone administration to imprinting errors.
Finally, apparent lack of remodeling of imprinted regions during preimplantation
has led to the argument that epigenetic disruption by ARTs is restricted to imprinted
genes. However, other genes have now been identified with differential gametic DNA
methylation that is retained through early preimplantation development (Smallwood et al.
2011, Kobayashi et al. 2012), termed “transient gDMRs”. These non-imprinted transient
gDMRs later acquire methylation on the unmethylated allele, described either at midgestation or in adult tissues. Genome-scale studies are needed to determine the scope of
epigenetic instability at non-imprinted genes in gametes and embryos as a result of
infertility and ARTs to truly understand the breadth of their effects.
6.5

Conclusion
Assisted reproduction will continue to be a critical medical intervention for

infertile couples. To maximize the safety of these techniques, it is imperative to
understand how mechanisms involved in epigenetic regulation are affected by impaired
fertility and ARTs. The work in this thesis demonstrates the maternal control of genomic
imprinting regulation, and stresses the importance of extending studies of oocyte
manipulations to the embryo. While imprints are acquired normally, maternal effect
factors required for imprint maintenance are misregulated.
Epigenetic programming within the early embryo necessitates the recruitment of
specialized maintenance complexes, namely these maternal effect factors, to imprinted
regions to ensure epigenetic integrity. Continued studies in animal models and in humans
are required to fully understand the molecular mechanisms of these proteins in the
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regulation of imprints as well as how impaired fertility and ARTs induce epigenetic
changes and disease. This will lead to preventative measures, reducing the occurrence of
epigenetic perturbations and maximizing the safety of ARTs to ensure normal embryonic
development and healthy children born through assisted reproduction.
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Appendix 1: Supplementary Material - Chapter 4
The following figures were presented as supplemental data to the experiments presented
in Chapter 4, published as:

Denomme MM, Zhang L, & Mann MR (2011) Embryonic imprinting perturbations do
not originate from superovulation-induced defects in DNA methylation acquisition. Fertil
Steril 96 734- 738 e732

164

Supplementary Figure 4- 1s
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Kcnq1ot1 or Peg3 allele, and either an
unmethylated B6 or CAST H19 allele.
For each sample, 5 clones were
sequenced. Oocytes (indicated to left)
with a single methylation pattern, a
single genotype (B6 or CAST), and
identical non-CpG conversion pattern
(% indicated to the right) were
included in the analysis. Representative
oocytes shown. Black circles indicate
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Supplementary Figure 4- 2s Methylation analysis of individual oocytes with
cumulus cell (CC) contamination and/or polar body (PB) inclusion.
Expected methylation patterns for females and their oocytes for Snrpn, Kcnq1ot1
and Peg3 (top left) and H19 (top right) are shown. Only a single strand of oocyte DNA
was expected to amplify, either a methylated CAST (CM) or B6 (BM) Snrpn, Kcnq1ot1
or Peg3 allele, and either an unmethylated CAST (CU) or B6 (BU) H19 allele. For each
sample, 5 clones were sequenced. Oocytes (designation indicated to left) with multiple
methylation patterns, both genotypes (B6, B, and CAST, C), and/or multiple non-CpG
conversion patterns (% indicated to the right) indicative of multiple strand amplification,
were excluded from the analysis. Representative oocytes shown. Black circles indicate
methylated CpGs. White circles indicate unmethylated CpGs.
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Appendix 2: Supplementary Material - Chapter 5
The following figure is presented as supplemental data to the experiments presented in
Chapter 5, in preparation as:
Denomme MM, Zhang L, Macdonald WA, White CR & Mann MR (2014)
Superovulation causes misregulation of the maternal effect factor ZFP57 involved in
genomic imprint maintenance during preimplantation, in preparation.

Supplementary Figure 5- 1s ZFP57 Localization in Mouse Morula Embryos from
Spontaneously Ovulated and 10 IU Induced Females
The morula derived from a spontaneously ovulated oocyte has ZFP57
immunofluorescence staining (green) colocalized with Hoechst staining (blue) within the
nucleoplasm of blastomeres. The morula derived from an oocyte induced to ovulate by 10
IU hormone treatment possesses clouded and punctate ZFP57 immunofluorescence
staining (green) that is mislocalized to the cytoplasm of blastomeres, in addition to
nuclear staining. Re-used with permission from (Denomme & Mann 2013).
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